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ABSTRACT OF DISSERTATION
 
 
IDENTIFICATION OF NOVEL SLEEP RELATED GENES FROM LARGE SCALE 
PHENOTYPING EXPERIMENTS IN MICE 
 
Humans spend a third of their lives sleeping but very little is known about the physiological 
and genetic mechanisms controlling sleep. Increased data from sleep phenotyping studies 
in mouse and other species, genetic crosses, and gene expression databases can all help 
improve our understanding of the process.  Here, we present analysis of our own sleep data 
from the large-scale phenotyping program at The Jackson Laboratory (JAX), to identify 
the best gene candidates and phenotype predictors for influencing sleep traits.  
The original knockout mouse project (KOMP) was a worldwide collaborative effort to 
produce embryonic stem (ES) cell lines with one of mouse’s 21,000 protein coding genes 
knocked out. The objective of KOMP2 is to phenotype as many as of these lines as feasible, 
with each mouse studied over a ten-week period (www.mousephenotype.org). The 
phenotyping for sleep behavior is done using our non-invasive Piezo system for mouse 
activity monitoring. Thus far, sleep behavior has been recorded in more than 6000 mice 
representing 343 knockout lines and nearly 2000 control mice. Control and KO mice have 
been compared using multivariate statistical approaches to identify genes that exhibit 
significant effects on sleep variables from Piezo data. Using these statistical approaches, 
significant genes affecting sleep have been identified. Genes affecting sleep in a specific 
sex and that specifically affect sleep during daytime and/or night have also been identified 
and reported.  
The KOMP2 consists of a broad-based phenotyping pipeline that consists of collection of 
physiological and biochemical parameters through a variety of assays. Mice enter the 
pipeline at 4 weeks of age and leave at 18 weeks. Currently, the IMPC (International Mouse 
Phenotyping Consortium) database consists of more than 33 million observations. Our final 
dataset prepared by extracting biological sample data for whom sleep recordings are 
 
 
available consists of nearly 1.5 million observations from multitude of phenotyping assays. 
Through big data analytics and sophisticated machine learning approaches, we have been 
able to identify predictor phenotypes that affect sleep in mice. The phenotypes thus 
identified can play a key role in developing our understanding of mechanism of sleep 
regulation.  
KEYWORDS: Sleep, Bioinformatics, Gene-Phenotype Association, KOMP2, Predictive 
Modeling 
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CHAPTER 1 
Introduction 
 
Background 
There is a consensus that all mammals, and perhaps all animals sleep (Campbell 
and Tobler 1984, Tobler 2005). And yet, the function of sleep is so far unknown and it 
remains one of the biggest mysteries of biological sciences. The general criteria to 
establish whether an organism sleeps or not is based on several parameters that include 
behavioral quiescence, increased arousal threshold, circadian control of sleep onset, 
homeostatic sleep rebound, postural change, physiological correlates, and impaired 
performance after sleep deprivation (Cirelli and Tononi 2008). There are other 
parameters as well that establish a strong connection of sleep with ontogeny (Kayser and 
Biron 2016). These include developmental control of sleep onset and amount, reduced 
sleep depth with developmental progression, physiological and brain abnormalities 
related to sleep loss, behavioral abnormalities caused by juvenile sleep loss, correlation of 
brain remodeling with early sleep, larval sleep, and embryonic sleep. Based on the above-
mentioned criteria, it has been increasingly well established that in addition to mammals, 
model organisms such as Danio rerio (Zebrafish), Drosophila melanogaster (Fruitflies) 
and Caenorhabditis elegans (worms) also sleep (Campbell and Tobler 1984, McNamara, 
Capellini et al. 2008, Hartse 2011). 
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Two-Process Model 
The history of sleep research, though relatively short, has been eventful, and our 
understanding of sleep has constantly grown through the years. Researchers have tried to 
understand sleep using a variety of neuroanatomical, physiological, and behavioral 
approaches.  Examination of sleep behavior from a physiological perspective was first 
performed by Dr. Henry Pieron in 1913 (Piéron 1913). It was Dr. Nathaniel Kleitman 
who first studied regulation of sleep and wakefulness in 1920s and is considered as the 
“Father of American Sleep Research”. His work led to the discovery of rapid eye 
movement (REM) during sleep (Aserinsky and Kleitman 1953). More recently, 
molecular, genetic, and pharmacological methods have been used as well.   Although the 
basic functions of sleep are still unclear, sleep drive, sleep need and sleep propensity can 
be explained by the two-process model proposed by Alexander Borbely which states that 
sleep is regulated by a circadian process (Process C) and a homeostatic process (Process 
S) (Borbely 1982, Daan, Beersma et al. 1984, Borbely and Achermann 1992, Borbely 
1998). Here, the sleep drive represents the desire to sleep, sleep need refers to the 
requirement and duration, and propensity refers to the inclination to sleep. The process C 
is governed by the endogenous circadian clock and is independent of prior sleep or wake. 
This endogenous circadian clock can be entrained by external stimuli like light and free 
runs under constant conditions with a period of approximately 24 hours i.e. after the 
entrainment, the clock maintains its periodicity even in the absence of stimulus. The 
process S, on the other hand, is governed by previous sleep or wake, with drive for sleep 
increasing as the wake prolongs. The Suprachiasmatic Nucleus (SCN) is the master 
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circadian pacemaker that is both necessary and sufficient for the generation and 
maintenance of most circadian rhythms (Ralph, Foster et al. 1990). 
 
Figure 1. 1.: The two process model of sleep (Borbely 1982) 
 
The two processes are independent but interact with one another. Two principal 
properties of Circadian rhythms are entrainment to environmental cues, and a self-
sustained oscillation that maintains an approximately 24 h period and will free-run in the 
absence of any environmental cues. Entrainment or synchronization normally occurs via 
the 24 h solar cycle. The suprachiasmatic nucleus (SCN) is the dominant circadian 
pacemaker in mammals, and is located in the hypothalamus within the brain (Ralph, 
Foster et al. 1990, Provencio, Cooper et al. 1998). The SCN projections are sent to 
different parts of the brain, with a majority ending at the sub-paraventricular zone and the 
signals are relayed to dorsomedial hypothalamic nucleus. Projections from dorsomedial 
hypothalamic nucleus are sent to different hypothalamic regions that include inhibitory 
GABAergic projections to sleep promoting ventrolateral preoptic area (VLPO), and 
excitatory glutamatergic projections to wake promoting lateral hypothalamus (Saper, 
Scammell et al. 2005). The balance between wake and sleep is maintained via two 
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distinct groups of neurons from the tuberomammillary nucleus (TMN) and VLPO. The 
increase in firing rates in the VLPO neurons inhibits activity in wake promoting regions 
including TMN. Orexin/hypocretin is a wake promoting neurotransmitter and helps 
prevents rapid transition from wake to sleep. There are several hypotheses for the 
mechanisms underlying the homeostatic process, but they are not well understood (Dijk, 
Beersma et al. 1987). Adenosine has been proposed as a key molecule that plays a role in 
homeostatic sleep drive by acting on VLPO neurons through its accumulation in the basal 
forebrain during wakefulness (Porkka-Heiskanen and Kalinchuk 2011). 
 
Molecular mechanisms of sleep 
In terms of molecular mechanisms, the circadian regulation of sleep is much 
better understood than the homeostatic regulation. The molecular circadian pathway 
includes several genes. CLOCK (Clk) and BMAL1 are two basic helix-loop-helix 
(BHLH)-PAS domain proteins that dimerize and bind to E-box element (a consensus cis-
regulatory sequence) that drives transcription of Period genes (Per1, Per2, Per3) and 
Cryptochrome genes (Cry1, Cry2). Pers and Crys interact after translation and translocate 
to nucleus where they suppress Clk-Bmal1 activity, which in turn negatively regulates 
their own expression as well.  This negative feedback loop appears to be at the heart of 
the circadian pacemaker. Pers and Crys degrade over time, and Clk-Bmal1 dimers are 
reactivated, leading to a re-start of the cycle once again after roughly 24 hours (Reppert 
and Weaver 2001, Lowrey and Takahashi 2004). 
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Circadian clock genes that influence both circadian timing and sleep homeostasis, 
have been identified using ENU/EMS (Ethyl methanesulfonate) mutagenesis techniques 
(Vitaterna, King et al. 1994, Kloss, Price et al. 1998, Kapfhamer, Valladares et al. 2002, 
O'Hara, Ding et al. 2007, Cirelli 2009). These gene include Clock and Rab3a in mice, and 
Per and Dbt in flies.  Discovery of these clock genes led to identification of many others 
(Bmal1/Cyc, Cry1,2, Per1,2,3, etc.) that also underlie circadian and homeostatic aspects 
of sleep. However, many of these mutations produce only subtle phenotypes, which are 
difficult to detect and are affected by genetic background (Nadeau 2001). Approaches 
using traditional mouse strains, genetic crosses, and QTL strategies have also identified a 
modest number of genes that influence sleep including Homer1a, Acads (acyl-coenzyme 
A dehydrogenase), and Rarb (Retinoic acid receptor beta) (Tafti, Petit et al. 2003, Drager 
2006, Maret, Dorsaz et al. 2007). A disadvantage of traditional QTL approaches is that 
they are subject to limited mapping resolution, and identifying the causal gene(s) is often 
difficult or not undertaken (Tabor, Risch et al. 2002, Churchill, Gatti et al. 2012), 
although this situation is improving with recent advances in mapping populations and 
related approaches (Jiang, Scarpa et al. 2015).    
 
Sleep-wake monitoring in model organisms      
Model organisms have played a key role in our understanding of sleep at both 
genetic and physiological levels. Much of this has been possible because of large-scale 
studies allowing for high-throughput screening for sleep related phenotypes (Joshi and 
O'Hara 2014, Sethi, Joshi et al. 2015, Funato, Miyoshi et al. 2016). Being able to perform 
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sleep-wake monitoring in a high-throughput manner is key for future developments in 
sleep research because that allows for studies to be done at a larger scale. Below is a short 
review that provides an overview of high-throughput sleep-wake monitoring techniques 
in the four most widely used model systems in sleep research: Caenorhabditis elegans, 
Drosophila melanogaster, Danio rerio, and Mus musculus. 
 
Caenorhabditis elegans 
C. elegans was introduced as a model organism for understanding development 
and the nervous system in 1960s (Brenner 1974). The life cycle of C. elegans is 
comprised of an embryonic stage, four larval stages, and adulthood. At the end of each 
larval stage, the organism undergoes molting wherein a new cuticle is synthesized and the 
older one is shed. Before each molt, there is a state called “lethargus” which is a 
quiescent behavioral state that is similar to sleep (Raizen, Zimmerman et al. 2008). It is a 
reversible state with reduced responsiveness to external stimuli and cessation of feeding 
and motion (Cassada and Russell 1975, Raizen, Zimmerman et al. 2008).  
Initial studies for lethargus relied on single worm recordings on agar plates seeded 
with bacteria (Van Buskirk and Sternberg 2007, Raizen, Zimmerman et al. 2008). High-
throughput approaches for activity monitoring in worms relies on microfluidics 
technology that allows for encapsulating worms in an array of droplets on a chip (Shi, 
Wen et al. 2010, Belfer, Chuang et al. 2013). In the method presented by Belfer et al, 
worms are housed in sub-microliter droplets with E.coli as food source, and is called the 
Caenorhabditis-in-drop (CiD) technique. Imaging can be performed by bright field 
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microscopy for several days throughout lethargus for at least 24 worms thus allowing for 
high-throughput analysis of complex behavior.  
 
Drosophila melanogaster  
Drosophila exhibits a sleep-like behavioral state called “Rest” (Hendricks, Finn et 
al. 2000). During rest, flies exhibited extended periods of immobility with reduced 
responsiveness to natural or mechanical stimulation, lasting up to 2.5 hours with 
uniformly characteristic resting locations and postures in isolated and groups housing 
conditions. Homeostatic regulation was also observed with significant rebound after sleep 
deprivation, supporting the idea that Drosophila “rest” is in fact a sleep or sleep-like 
state. 
The current standard method for Drosophila sleep-wake monitoring involves 
signals recorded by infrared beam breaking, by flies that are housed within a tube. The 
system was first developed by Dr. Yoshiki Hotta who used an incandescent lamp with a 
filter transmitting wavelengths above 800 µm (Konopka and Benzer 1971). The system in 
its current high-throughput avatar is called Drosophila Activity Monitoring System 
(DAMS) (Trikinetics, Waltham, MA), and is widely used in Drosophila behavioral 
analysis. The DAM2 monitor can measure locomotor activity of 32 individual flies. The 
setup consists of 32 tubes with each tube containing food at one end, the fly, and a cotton 
plug or a plastic cap at the open end. Infrared beam breaking count is maintained for each 
channel throughout the duration of experiment and the data can be analyzed using the 
software produced with the system. 
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For sleep studies, a major limitation of DAMS is its low sensitivity towards fly 
movements. A small movement that can be an interruption in sleep might not be recorded 
unless the fly crosses the path of infrared beams. It is also not possible to assess the 
magnitude of movement, since a large movement from one end of the tube to another is 
counted as a single beam break. An alternative method with video analysis has been 
proposed that overcomes these limitations, and also provides more accurate data about 
sleep architecture, along with precise location of the fly within the tube. 
 
Danio rerio 
Zebrafish has emerged as a model for studying sleep and wake behavior in the last 
decade. Quiescent behavior that meets the criteria for a sleep like state exists in both 
larval and adult stages of Zebrafish (Yokogawa, Marin et al. 2007, Prober, Zimmerman et 
al. 2008, Zhdanova 2011). The quiescent behavior in Zebrafish is regulated by an 
endogenous rhythm with bouts of inactivity occurring mostly at night. These bouts of 
quiescence can last for several minutes or longer and are considered sleep if they last for 
at least 1 minute in larvae and for at least 6 seconds in adults. There is increased arousal 
threshold and decreased responsiveness during quiescence and increased sleep amount 
(rebound) after sleep deprivation thus fulfilling the criteria of homeostatic regulation of 
sleep. 
Similar to Drosophila, infrared beam breaking is used extensively to study 
locomotor activity in Zebrafish. Though it is a very good technique to study circadian and 
gross locomotion activity, it suffers from the same limitations as discussed earlier for 
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sleep related studies in fruit flies. This makes automated digital video analysis of sleep-
wake behavior an attractive alternative. There are several commercially available activity 
tracking systems for Zebrafish larvae and adults. The prominent of these are distributed 
by by Noldus IT (Wageningen, Netherlands) and Viewpoint Life Sciences (Montreal, 
Canada). Along with this, there is an option for researchers to develop their own setup 
with high-speed camera and custom algorithms developed for analyzing Zebrafish 
responses to outside stimuli. 
 
Mus musculus 
Among the mammalian systems, sleep has been extensively studied in mice. With 
a wide variety of inbred strains specific to sleep phenotypes, well-established behavioral 
assays, and a strong genetic toolbox, it is indeed an efficient model system for studying 
sleep. Although mice are nocturnal, the circadian system is well conserved across all 
mammals.  Moreover, among the model organisms discussed thus far, the mouse best 
satisfies all sleep criteria, and as a mammal, its neuroanatomy, physiology, and genetics 
are much closer to humans thus making it the most attractive model system to study 
human sleep.  Mouse sleep differs from humans in two aspects: mice sleep more during 
the day, and sleep in mice is highly fragmented. Similar to human sleep, the sleep 
measures in mice have traditionally been focused on neural surrogates in which the sleep 
is described in terms of Rapid Eye Movement (REM) and Non-Rapid Eye Movement 
(Non-REM or NREM) states. 
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Electroencephalogram (EEG) has been the gold standard for sleep studies in mice 
(as in humans) wherein sleep structure and the underlying neurophysiology can be 
assessed by analyzing EEG power spectra for different sleep-wake states (Davis, Davis et 
al. 1937, Lo, Chou et al. 2004). The EEG sleep studies in mice have played a great role in 
advancement of our understanding of sleep (Funato, Miyoshi et al. 2016). EEG 
recordings are generally straight-forward in humans, but in mice, the electrodes should be 
surgically implanted, making it an invasive, time-consuming and expensive process. 
These limitations make it unsuitable for use in high-throughput studies involving large 
numbers of animals. In addition, the invasive aspect of EEG with side effects of surgery 
and electrodes implanted for large periods of time can bring about a change in the sleep 
structure of an organisms, thus causing a confound in the study itself. When in-depth 
EEG studies are not required, ethical and cost restraints demand use of a non-invasive 
approach that can provide sleep variables like duration, bout length (duration of single 
sleep episode), number of bouts, and sleep latency, which in a high-throughput study can 
provide valuable information about sleep-wake behavior. 
Two non-invasive techniques with a potential for high-throughput screening have 
gained prominence. Pack et al (McShane, Galante et al. 2012) used video monitoring 
with infrared beam breaking based object recognition algorithm to evaluate sleep. By 
comparing with EEG data, they identified that ≥40 s of inactivity was highly correlated 
with sleep in mice. Fisher et al have proposed a similar technique that also records 
additional variables that can be used for studying anxiety or behavioral inhibition 
phenotypes (Fisher, Godinho et al. 2012). Noldus IT (Wageningen, Netherlands) and 
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Pinnacle Technology (Lawrence, KS, USA) provide commercial systems that use video 
recording for sleep studies and proprietary software for data analysis.   
Another approach is to monitor sleep-wake activity through piezoelectric sensors 
positioned on the floor of a mouse cage. Results from such sensors were first reported by 
Megens et al (Megens, Voeten et al. 1987) where they were used to study changes in 
activity in response to different drugs and dosages. Flores et al (Flores, Flores et al. 2007) 
implemented a novel pattern recognition algorithm that identified sleep when the animal 
assumed a specific posture and regular motions associated with breathing were recorded, 
and wake was classified in the form of large amplitude spikes. The limitations with this 
initial system included variable noise and a computationally expensive algorithm, where 
data from a single mouse took nearly 10 hours to process on a regular desktop PC. 
Donohue et al (Donohue, Medonza et al. 2008) built on this initial attempt, and 
developed a piezoelectric sleep-wake monitor that overcomes these limitations with a 
simpler more robust algorithm and ergonomics, and became suitable for high-throughput 
sleep studies in mice. A single unit consists of four cages and detects motion through a 
Polyvinylidine Difluoride (PVDF) sensor on the cage floor. With respect to EEG, it has 
classification accuracy of more than 90% for sleep-wake. It can generate sleep statistics 
for large number of mice over long periods of time, and has been used in several large-
scale sleep studies, with continual improvement in the software and hardware features 
(Philip, Sokoloff et al. 2011, Sethi, Joshi et al. 2015). 
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KOMP2 
International Knockout Mouse Consortium (IKMC) aimed to generate mutant 
embryonic stem cells (ES) for every coding gene in the mouse genome on the 
C57BL/6NJ (also called Black-6) background. This was the first generation of the 
project, also called as Knockout Mouse Project (KOMP). In the next stage, these mice are 
being phenotyped as part of Knockout Mouse Phenotyping Program (KOMP2). As live 
mice are made from the ES cell lines, these single-gene knockouts undergo a core set of 
broad-based phenotyping screens at the KOMP2 centers as part of the IMPC (Abbott 
2010, Bradley, Anastassiadis et al. 2012, Brown and Moore 2012). At The Jackson 
Laboratory KOMP2 Center (JAX-KOMP2) sleep is part of this pipeline, and the results 
thus far are described in this report (Chapters 2 and 3). Such an undertaking has many 
advantages over individual lab efforts, as each mouse can be examined for many traits 
across many domains, quality control and bioinformatic approaches can more easily 
assess confounding variables, and the many different traits can be cross-correlated to 
reveal new relationships. This broad-based platform will expedite the functional 
annotation of genes, especially those that are currently most poorly understood, and 
promote continued utilization of these knockout mice for future studies (Bradley, 
Anastassiadis et al. 2012, Brown and Moore 2012). 
In the first part of my thesis (Chapter 2), I have used data from the JAX Pipeline 
for sleep phenotyping from piezo system to identify gene knockouts in which sleep 
significantly differs from control mice. By analyzing data from more than 6000 mice 
belonging to 343 gene knockouts using multiple statistical approaches, I have identified 
122 genes that affect sleep duration and quality. Sex-associated differences in genes 
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affecting sleep have been identified, along with genes that affect sleep only during a 
specific circadian phase. In the second part (Chapter 3), I have used sophisticated 
machine learning and data analysis techniques to identify predictor phenotypes for sleep 
behavior in KOMP2. By performing partial data simulation and data modeling through 
multiple regression, decision trees, and random forest algorithms, I have identified key 
phenotypes in the KOMP2 that can be used as a predictor for sleep behavior.  
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CHAPTER 2 
Noninvasive sleep monitoring in large-scale screening of knock-out mice reveals 
novel sleep-related genes  
 
Background 
Sleep is a complex behavior common to all birds and mammals, and probably 
most or all other vertebrates and invertebrates with a nervous system (Tobler, Franken et 
al. 1992, Tobler 2005). Regulated by a multitude of neuronal processes and indirectly by 
gene networks, it is a process vital for an organism’s health and survival. Sleep has been 
suggested to have a role in functions such as learning, memory consolidation, energy 
restoration, synaptic optimization and recently it has also been implicated in the clearance 
of metabolites, including Aβ (Tononi and Cirelli 2006, Tucker, Hirota et al. 2006, 
Marshall and Born 2007, Nishida, Pearsall et al. 2009, Diekelmann and Born 2010, Xie, 
Kang et al. 2013, Krueger, Frank et al. 2016). Aβ (Amyloid beta) are main components of 
the amyloid plaques found in the brains of patients suffering from Alzheimers disease. 
Genetic manipulations have advanced our knowledge about some aspects of 
sleep, including influences on the sleep EEG, sleep disorders, brain areas regulating sleep 
processes, and molecular pathways underlying sleep and its regulation. However, 
relatively few gene mutations or gene knockouts in mice have been examined for effects 
on sleep, and there are still many unresolved questions regarding the biological need for 
sleep, functions of sleep, and the genetic and physiological basis of sleep homeostasis 
(Rechtschaffen 1998, Cirelli 2009, Vassalli and Dijk 2009) that could be addressed with 
insights from model organisms.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
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 There have been numerous efforts to address these questions utilizing a variety of 
animal models, including mice. These efforts range from individual labs studying specific 
knockout mice, to large-scale QTL (quantitative trait loci) and genome-wide projects 
including phenotype-driven ENU (N-ethyl-N-nitrosourea) mutant screens involving 
many labs, and gene-driven knockout mouse phenotyping programs (Gondo, Fukumura 
et al. 2009). 
A major bottleneck in large-scale genetic studies of sleep is the difficulty, 
expense, and time demands of traditional EEG/EMG studies. While knockout studies of 
selected target genes such as neurotransmitter receptors have found modest effects on at 
least one sleep parameter, relatively few genes have been examined (O'Hara, Jiang et al. 
2017).  Using a higher throughput, non-invasive approach allows for much larger 
numbers of mice to be examined (Flores, Flores et al. 2007, Pack, Galante et al. 2007, 
Donohue, Medonza et al. 2008, Philip, Sokoloff et al. 2011, Mang, Nicod et al. 2014). 
Our approach utilizes a sensitive piezoelectric film across the mouse cage floor, and is 
especially well suited to characterization of large-scale resources such as the International 
Knockout Mouse Consortium (IKMC) (Ringwald, Iyer et al. 2011).  
 
Methods and Design  
Generation of knockout mice  
IKMC mouse mutants are generated on a C57BL/6NJ mouse background that 
have either null alleles, which have an entire locus removed or “knockout-first” alleles, 
which permits generation of conditional alleles by utilization of site-specific recombinase 
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as described previously (Skarnes, Rosen et al. 2011, Schofield, Hoehndorf et al. 2012). 
C57BL/6NJ is a substrain of the original C57BL/6 (commonly called B6 or Black-6) 
which is a well-characterized inbred strain and has been the most commonly used one in 
biomedical research. It also serves as a reference strain for the mouse genome, making it 
an ideal choice for this effort, although differences between the C57BL/6J and 
C57BL/6NJ substrains exist (Keane, Goodstadt et al. 2011, Simon, Greenaway et al. 
2013, Mekada, Hirose et al. 2015).  Here onwards, the C57BL/6NJ will be referred to as 
B6NJ for the remainder of chapter. 
As part of the JAX-KOMP2 phenotyping pipeline, each mouse is 
comprehensively phenotyped for over 200 measurements, from age 4-18 weeks, for a 
range of morphological, physiological and behavioral traits including many disease 
relevant parameters pertaining to neurobehavior, metabolism, immune, cardiovascular, 
sensory, and musculo-skeletal systems, followed by terminal collection of blood and 
histopathology (Morgan, Simon et al. 2012) (Fig 2.1). Additional tests such as light/dark 
and hole-board exploration tests, rotarod, and sleep, are unique to the JAX-KOMP2 
pipeline. Sleep is evaluated using a PiezoSleep System (Signal Solutions, LLC, 
Lexington, KY), a non-invasive, high throughput sleep-wake monitoring system (details 
provided in following sections). The primary traits analyzed are total sleep duration 
averaged across 24 h, 12 h light phase and 12 h dark phase, and average sleep bout 
lengths (across 24 h, 12 h light, and 12 h dark phase), and breath rate during sleep. 
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Figure 2. 1.: Phenotyping Pipeline at The Jackson Laboratory (Wt : Wildtype) 
 
Sleep recording with piezoelectric system 
Sleep and wake states were determined using the PiezoSleep System (Flores, 
Flores et al. 2007, Donohue, Medonza et al. 2008, Mang, Nicod et al. 2014). It is a quad-
cage and piezoelectric sensor system that comprises plexiglass cages lined with 
piezoelectric films across the cage floor (Signal Solutions Llc, Lexington, KY). These 
piezoelectric films are highly sensitive to pressure changes caused by different 
movements and sleeping postures, and even pressure variations from breathing are also 
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detected. The software provided with the system records the changes in amplitude of 
electrical signals generated by force on the piezoelectric sensors. Sleep states are 
characterized by quasi-periodic signals with low variations in amplitude, whereas 
wakefulness and rest states are characterized by irregular transient and high amplitude 
pressure variations corresponding to voluntary body movements and weight shifting. The 
piezo system has been validated with simultaneous EEG and human scoring of mice 
demonstrating a classification accuracy of over 90% in mice (Donohue, Medonza et al. 
2008, Mang, Nicod et al. 2014). 
  
Animal housing and Phenotyping  
This study utilizes control and KO mice generated on B6NJ background. From 
wean age, mice were housed at 3-5 mice per pen in pressurized, individually ventilated 
cages using pine shavings as bedding, with free access to acidified water and food 
(LabDiets 5K52, LabDiet, Scott Distributing, Hudson, NH). The housing facility was 
maintained on a 12:12 light/dark cycle starting at 0600. At 15 weeks of age, mice were 
removed from their home cages and placed into individual cages of the piezo system. The 
system used in the JAX-KOMP2 pipeline is comprised of 17 4-cage units, allowing for 
simultaneous assessment of up to 72 mice per 5-day experiment window. During sleep 
testing, light cycle and food and water access were as that of standard housing conditions. 
A minimum amount of pine shavings was provided to each cage to allow sufficient 
detection of pressure signal. In each testing week, 10 control B6NJ animals (five females 
and five males) and 3-19 animals per KO line were tested. Females and males of all KO 
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strains were analyzed, with a pipeline throughput goal of testing eight animals of each 
sex for all screens. 
 
Data Analysis 
We began with a dataset with observations from 8849 mice (4446 females, and 
4403 males). In the KOMP2 pipeline, a rigorous quality check is performed before the 
data is approved for release. In the final dataset, observations only from mice that had 
been approved to have finished the KOMP phenotyping pipeline were included in the 
analysis. One of the outputs of piezo sleep-wake system is data confidence metric that 
ranges from 0 through 1 to assess the signal quality and/or outlying signal behavior. Any 
of the sleep recordings with a data confidence value below the threshold of 0.6 were 
excluded from the analysis. The control mice were also screened for outliers based on 
extreme high/low values for their sleep/wake parameters. Multivariate outlier analysis 
was carried out by computing Mahalanobis distance (md) (Mitchell and Krzanowski 
1985). In brief, it calculates multidimensional distance of each of the observations from 
the centroid mean vector of all measured variable scores, (Bassett, Gogakos et al. 2012). 
Data analysis was carried with both outliers included and excluded, and in this dataset the 
results remained the same. The goal of removing outliers is to remove the observations 
that might distort the segmentation of the data which is key in identifying candidate 
genotypes in later steps. As more data for sleep behavior becomes available in KOMP2, it 
can potentially help in identifying genes that might be missed because of the increased 
variance in the data caused by the outliers. MD assesses cutoff values for outliers based 
on quantiles in chi-square distribution. At default quantile threshold of 0.975, a cutoff 
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value of 4.0 was generated with 114 Control mice having md values above the cutoff, and 
were thus excluded from the analysis. The final dataset used for analysis contained 6350 
mice belonging to 343 KO strains and control mice. This final dataset consisted of 1884 
Control (918 Females; 894 Males), and 4466 KO (2250 Females; 2216 Males) mice. 
One-way analysis of variance (ANOVA) was performed for each sleep variable and 
breath rate, and posteriori multiple comparisons were done using Dunnett’s test to 
identify genotypes showing significant difference/s with respect to the control group 
(Dunnett 1955). For multiple comparisons, p-values adjusted for family wise error rate 
(FWER) were computed. Similar analysis was done to identify genotypes with sex-
specific effects. 289 of the knockout cohorts containing at least 3 females and 3 males 
each were included in this analysis. Significance values for simple and interaction effects 
between Genotype and Sex were computed through Factorial ANOVA and effect sizes 
were estimated. For all of the analyses of the sleep-wake parameters under consideration 
(listed above), an adjusted p-value of less than 0.05 was considered significant.    
Principal component analysis (PCA) was performed on six of the sleep variables 
under consideration: sleep durations and bout lengths across 24 hours, and 12 hours 
during light and dark phases. PCA is a method for multivariate analysis through 
dimension reduction i.e. it is used to reduce the number of variables into principal 
components (PC) that account for most of the variance of the original variables. The first 
principal component that accounts for majority of variance in the data can be considered 
the summary variable representing the data. Genotypes significant for the first principal 
component were identified and were considered to be the ones that affect overall sleep.  
In the final step, mean values for each sleep variable from piezo system were computed 
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for all genotypes and multivariate Mahalanobis distance outlier analysis was performed 
for the whole dataset. The genes identified as outliers were considered to have maximum 
effect on sleep variables. The PCA and outlier analysis described above should be 
considered an extension of the significance analysis performed through ANOVA and 
Dunnett’s test. These were conducted with the goal of identifying the genes that appear in 
the results of all three analyses and will be considered key candidate genes affecting sleep 
in mice. A final list of all significant results was prepared and these were presented as the 
sleep related candidate genes. 
Gene network analysis was conducted using GeneMANIA, which is a tool for 
analyzing sets of genes (Warde-Farley, Donaldson et al. 2010). The Cytoscape software 
for network visualization contains a dedicated plugin for GeneMania and was used in this 
analysis. For phenotype associations, data was collected for final list of sleep related 
candidate genes from IMPC database (mousephenotype.org) through batch query. The 
complete schematic of data analysis procedure has been shown in Figure 2.2. 
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Figure 2. 2.: Schematic of data analysis procedure 
 
Geneweaver software was used to perform geneset similarity analysis (Bubier, 
Langston et al. 2017). Data analysis was performed in R programming environment in 
the R Studio. The outlier analysis was done using Chemometrics package (Varmuza and 
Filzmoser 2016), and Dunnett’s test was performed using DescTools package (Signorell 
2015). Package ggplot2 was used to prepare plots (Wickham 2016). 
 
Results 
B6NJ/Control mice 
We found that female B6NJ have a significant reduction in total sleep time (41.83 
± 0.12%; Males: 45.11 ± 0.12%; t-test, p<0.001), as well as reduced sleep in both the 
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light (Females: 62.13 ± 0.16%; Males: 63.01 ± 0.15%; t-test, p<0.001) and dark periods 
(Females: 21.53 ± 0.17%; Males: 27.21 ± 0.18%; t-test, p<0.001) compared to B6NJ 
males, though it is less pronounced during the light phase as compared to dark phase (Fig 
2.3A).           Similar to sleep duration patterns, females also show shorter bout lengths 
measured across 24 h (Females: 369.68 ± 2.06 s; Males: 444.78 ± 2.55 s; t-test, p<0.001), 
and during both the dark (Females: 198.57 ± 1.44 s; Males: 275.85 ± 2.2 s; t-test, 
p<0.001) and light phases (Females: 539.29 ± 3.03 s; Males: 619.75 ± 3.55 s; t-test, 
p<0.001) (Fig 2.3B). Overall, B6NJ female mice have reduced sleep duration and shorter 
bout length than their male counterparts (Table 2.1).  
 
Piezo Variable Female Male p_value 
Sleep Daily Percent 41.83 +- 0.12 45.11 +- 0.12 p<0.001 
Sleep Dark Phase Percent 21.53 +- 0.17 27.21 +- 0.18 p<0.001 
Sleep Light Phase Percent 62.13 +- 0.16 63.01 +- 0.15 p<0.001 
Sleep Bout Lengths Mean 369.68 +- 2.06 444.78 +- 2.55 p<0.001 
Dark Sleep Bout Lengths Mean 198.57 +- 1.44 275.85 +- 2.2 p<0.001 
Light Sleep Bout Lengths Mean 539.29 +- 3.03 619.75 +- 3.55 p<0.001 
Breath Rate During Sleep Mean 2.58 +- 0.01 2.82 +- 0.01 p<0.001 
Table 2. 1.: Sleep comparison between male and female control mice. Comparison of 
mean and standard deviation values in males and females for piezo variables in 
control mice. P-values were calculated by comparing means via t-test. 
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Figure 2. 3.: Sleep–wake patterns in control mice under baseline conditions. 
Average percent sleep across three consecutive days analyzed over (A) 24 h, dark 
phase, and light phase. Female mice show reduction in sleep duration across 24 h 
and during the light and dark phase. (B) depicts average bout length in seconds (s) 
over 24 h, dark phase, and light phase. Females had shorter average bout lengths 
across all phases. Error bars represent Standard Deviation. ***P < 0.001 in t-test. 
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Knockout mice:  
This report presents the analysis of piezo system sleep recordings from 343 KO 
strains. Of these, 55 KO strains showed significance at p<0.05 (adjusted for FWER) in 
Dunnett’s post hoc analysis for one or more of the sleep variables recorded (Figure 2.4, 
Supplementary Table A.1). Across the 24-hour period, reduction in sleep percent (total 
sleep) was observed in Ppp1r9b, Pitx3, Ap4e1, Cdc20, Vsig4, and Bzw2 KO strains, 
while increased total sleep was seen in Cbln3, Tpgs2, and Ccl26 compared to control 
mice. During light phase, the reduced sleep percent was recorded in Pitx3, Ppp1r9b, 
Hsd17b1, Tmem79, Bzw2, Nrcam, Kcnh3, and Htr3b and longer sleep duration in Eogt, 
Gjd4, Ccl26, epgn, Ncald, Neurl2, Npm3, Serpinb5, Htr1f, Ifnl3, Foxo3, Dnaja4, Cpb1, 
Bex4, Ttll6, Rimklb, Ydjc, Zfp961, Slc46a3, and Slc8b1. KO mice. During dark phase, 
sleep durations was reduced for Ppp1r9b, Vsig4, Rimklb, and Mylip knockouts, and 
increased for Cbln3, Macrod2, and Postn. Additionally, as compared to controls, mean 
bout length was significantly reduced across 24h in Pitx3, Hsd17b1, Myh1, Rnf10, 
Myo3b, Ap4e1, and Ppp1r9b, and increased in Tmem136 mutant mice. In light phase, 
bout lengths were significantly shorter in Pitx3, Hsd17b1, Ptpru, Myh1, Ppp1r9b, Ap4e1, 
and Nrcam and longer in Arrb2, Adck2, Slc8b1, Zfp961, Htr1d, Zbtb4, Tmem136, Emp1, 
and Ipp relative to control mice. During dark phase, significantly shorter mean bout 
lengths were seen in Stx16, Rimklb, Rnf10, Myo3b, Bex4, Ppp1r9b, Tmem151b, Zzef1, 
Ap4e1, Rab27b, Tmod2, Nes and Mylip, and longer bout lengths were found in case of 
Ghrhr (Figure 2.3, Supplementary Figure A.1).  
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Figure 2. 4. Gene KO that differed significantly from control mice in percent sleep 
and mean bout lengths. Percent Sleep: 24 h (A), in light phase (B) and in dark phase 
(C); Bout Lengths: 24 h (D), in light phase (E) and in dark phase (F). (G) KO strains 
that differed significantly compared to control mice in their breathing rates. 
 
Genes affecting specific sex 
Similar analysis (as described above) was performed for 289 KO strains, each of 
which had at least 3 females and 3 males to evaluate sex-specific differences in sleep 
parameters measured. Along with significant simple effects of genotype and sex, a 
significant interaction effect was also observed for sleep percent and mean bout lengths 
over 24 hours, light phase and dark phase. Effect size was also calculated for each piezo 
parameter, which represents the strength of relationship between variables and tell about 
how much of an effect sex, genotype, or interaction had on a sleep parameter. Effect sizes 
have been reported as eta squared which represents the variance in piezo variable 
explained by either genotype, sex, or interaction between them. According to Cohen’s 
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guidelines, effect sizes can be defined as small (0.01), medium (0.06), and large (0.13) 
(Cohen 1992). Based on this criterion, the interaction between genotype and sex, though 
significant had an intermediate effect with values nearly 0.05 for all piezo variables 
(Table 2.2).  
Piezo Variable Effect Size (Ƞ2) p-value 
Daily Sleep Percent (24 h) 0.061 p<0.05 
Light Phase Sleep Percent 0.053 p<0.05 
Dark Phase Sleep Percent 0.052 p<0.05 
Bout Length mean (24 h) 0.047 p<0.05 
Light Phase Bout Length 0.044 p<0.05 
Dark Phase Bout Length 0.051 p<0.05 
Breath Rate during Sleep 0.046 p<0.05 
Table 2. 2.: Effect size and p-values for sex-genotype interactions in piezo variables 
 
For the overall sleep percent over 24 hours, Pitx3 and Ppp1r9b had significantly 
reduced sleep in both males and females. Among males, significant reduction in sleep 
was also observed in Cdc20, Chn1, Mettl7b, and Ptpn5, and in females, it was reduced in 
Ap4e1, Col18a1, and Tmem79, and was significantly increased in Cbln3, Ccl26, Rab24, 
and Ydjc. During light phase, sleep percent is reduced in Pitx3, and Ppp1r9b, and 
increased in Slc8b1 in both males and females. Among males, the genotypes Cdc20, 
Bzw2, Hsd17b1, Parp16, and Prom2 had reduced sleep durations, and Dnaja4, Epgn, 
Epha10, Htr1f, and Zfp961 had significantly increased sleep percent. Among the 
genotypes specific to females, Col18a1, Kcnh3, and Nrcam had reduced sleep percent, 
and Ccl26, Ydjc, Cpb1, Npm3, Serpinb5, Slc46a3, and Zbtb4 had increased sleep percent 
during light phase. In dark phase, sleep durations were significantly reduced in Ppp1r9b, 
and increased in Macrod2, and Postn in both males and females. Mettl7b, Ptpn5, Mylip 
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and Tmod had lower values, and Parp8 and Postn had significantly higher values as 
compared to control in males. Among the females, Arrb2, Vsig4, and Zfyve26 had 
reduced sleep percent, and Myh1, and Cbln3 had increased sleep percent values as 
compared to controls during dark phase. Mean bout lengths over 24 hours had 
significantly reduced values for Pitx3 and Hsd17b1 in both males and females. In males, 
Mean bout lengths were significantly lower for Mettl7b, Ppp1r9b, Ap4e1, Rimklb, and 
Rnf10, and higher for Nfatc4. Among females, these were lower for Myh1, and Nes, and 
higher for Ghrhr, Prss56, and Tmem136. During light phase, mean bout lengths were 
found to be significantly lower in Pitx3 and Hsd17b1 in both males and females. They 
were also reduced in Mettl7b in males and Ptpru in females, and increased in Nfatc4 and 
Nat1 genotypes in males, and Slc8b1, Adck2, Zbtb4, Ipp, and Nrn1l in females. For mean 
bout lengths during dark phase, there were no genotypes that affected both males and 
females. Among the genotypes specific to males, the values were significantly lower for 
Ppp1r9b, Zfp961, Tmod2, Ap4e1, Rimklb, Rnf10, Stx16, Tmem151b, and Zzef1, and none 
of the genotypes had significantly higher values. In females, lower values as compared to 
control were seen for Pitx3, Hsd17b1, and Ptpru, and higher values were seen for Slc8b1, 
Adck2, Zbtb4, Ipp, and Nrn1l genotypes (Supplementary Table A.2).  
 
Principal Component Analysis 
 We performed additional analyses to identify sleep related genes based on 
multiple measures using Principal Component Analysis (PCA). We included standardized 
values for sleep percent and bout lengths for 24 hours, light phase and dark phase in our 
analysis. For our dataset, the first three principal components explained for more than 
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95% variability in the data, with PC1 accounting for 46.75% of the variability (Figure 
2.5B). Correlation between the principal component and the original variables is 
described in terms of loadings. There is a point of inflection in the eigenvalues after 4 
components (Figure 2.5A). However, fourth factor has eigenvalue less than 1, indicating 
that 3 components may best represent the data. 
The first PC1 had high loading values for each variable (mean loading = 0.4; 
Table 2.3). ANOVA with multiple comparison through Dunnett’s post hoc test of PC1 
resulted in 7 genotypes that showed significance. These genotypes are Ap4e1, Cdc20, 
Hsd17b1, Myo3b, Pitx3, Ppp1r9b, and Rnf10. Interestingly, the PC2 had positive 
loadings for sleep percent and negative loadings for bout lengths, and Arrb2, Cbln3, 
Dcaf10, Macrod2, Myh1, Parp8, Ppp1r9b, Rnf25, Tmem79, and Tpgs2 were significant. 
Similarly, PC3 had positive loadings for light phase and negative loadings for dark phase. 
The genes significant for PC3 include Adck2, Ajap1, Arf2, Bex4, Cldn13, Cpb1, Dnaja4, 
Dnajc14, Eogt, Epgn, Epha10, Gipc3, H1fx, Hsd17b1, Htr1f, Ifnl3, Ipp, Kcnh3, Macrod2, 
Mylip, Nfatc4, Npm3, Nrcam, Parp16, Pitx3, Postn, Rab3, Rimklb, Serpinb5, Slc1a1, 
Slc46a3, Slc8b1, Stx16, Tdrkh, Tmod2, Ttll6, Zfp219, and Zfp961. Based on the results 
from ANOVA of individual variables and PC3, we propose these genes as candidate 
genes that affect sleep in a specific circadian phase. 
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Figure 2. 5.: Principal Component Analysis Plots 
A. Eigenvalue plot for principal components. B. Variance explained by individual 
principal components. 
 
Piezo Variables PC1 PC2 PC3 PC4 
Sleep Daily Percent -0.433 -0.536 -0.002 -0.015 
Sleep Light Phase Percent -0.347 -0.434 0.504 0.337 
Sleep Dark Phase Percent -0.287 -0.35 -0.632 -0.446 
Sleep Bout Length Mean -0.467 -0.482 -0.034 -0.187 
Light Phase Bout Length Mean -0.446 -0.291 0.439 -0.434 
Dark Phase Bout Length Mean -0.438 -0.291 -0.392 0.681 
Table 2. 3.: Loading values for PCA 
 
Outlier Analysis 
The analysis through ANOVA and PCA is based on the differences between 
individual genotypes and the controls and it identifies genes that are deviating from the 
normal. As an additional strategy to identify genes affecting sleep, MD for multivariate 
outliers were calculated for means of sleep percent and bout length variables of all KO 
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strains. Candidate genes were identified with MD above cutoff value of 3.80 (at default 
quantile threshold of 0.975). The advantage with this analysis is that it helps in 
identifying genotypes that have extreme values that might have been missed earlier while 
comparing with controls. And if genes that were significant earlier appear again this 
analysis, then it acts as additional validation of results. Based on outlier analysis, the top 
candidate genes for sleep are Akr1d1, Cacna2d3, Enox1, Fndc4, Galnt12, Gpr156, 
Hsd17b1, Ipp, Masp1, Mos, Myh1, Myo3a, Nek2, Ovch2, Pfdn6, Pitx3, Postn, Ppp1r9b, 
Ptpru, Rab3c, Rab3gap2, Rbm4b, Serpinb5, Srcin1, Tas2r138, Tmem79, Tnfsf18, 
Tubb4a, and Vsig4.  
 
Breath rate during sleep 
Breath rate values during sleep were analyzed using the same methods and 
analytical approach as described above, genes affecting breath rate during sleep, and 
genes affecting breath rate in specific sex were identified. Significant difference was 
found in breath rate values between genotypes (p<0.05, ANOVA). In Dunnett’s post-hoc 
analysis, 26 genotypes significantly differed from control with reduced values in Myh1, 
Tppp, Nes, Dcaf10, Pkp4, Lin28b, Stx16, C1qa, Il12rb2, Dnaja4, Acsf2, Rab36, Carf, 
Slc8b1, Mag, Mettl7b, Cd84, Htr1f, Rab3ip, Zfp689, Tdrkh, Cfb, Slc46a3, and Krt9, and 
increased valued for Crym, and Cbln3 (Figure 2.4G). Among these, Acsf2, Lin28b, Myh1, 
Nes, Rab36, and Tppp were significant for both females and males. Genes specific to 
males include Mettl7b, Ppp1r9b, Epgn, Postn, Stx16, Tmem151b, Zzef1, Adck2, Ajap1, 
BC030499, C1qa, Carf, Cers5, Ces4a, Cfb, Dcaf10, Il12rb2, Loxl1, Mag, Pkp4, Rab3ip, 
Rxfp4, Slc1a1, Tdrkh, Thsd1, and Zfp689 in which breath rate during sleep was 
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significantly reduced and Prokr1 that had values significantly higher than control mice. In 
female mice, breath rate was significantly higher than control mice in Cbln3, Crym, and 
Igsf11.  
 
Key Candidate Genes for Sleep 
Thus far gene lists were prepared for ANOVA, PCA, and MD analysis. Here PCA 
and MD can be considered more of validation steps rather than independent analysis. 
Genes that constantly appear in 2 or more of these lists can be considered as strong sleep 
related candidates. The gene lists prepared for ANOVA, PCA and MD analysis were 
analyzed to identify genotypes that appear in all of them. We consider them to be key 
candidate genes affecting sleep percent and bout lengths over 24 hours and light and dark 
phases. These genes are Hsd17b1, Ipp, Myh1, Pitx3, Postn, Ppp1r9b, Serpinb5, and 
Tmem79 (Figure 2.6). A final list of 122 unique sleep related candidate genes was created 
by combining results from all our analysis.  
 
Figure 2. 6.: Venn diagram representing number of genes from ANOVA, PCA, and 
Outlier analyses 
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Gene Network Analysis 
With the goal of investigating relationships between results from our analysis and 
some of the known circadian and sleep-influencing genes, network analysis was 
performed to find associations between genes through large set of data that include 
protein and genetic interactions, pathways, co-expression, co-localization, protein domain 
similarity, and predicted networks by OPHID (Online Predicted Human Interaction 
Database). The genes selected for this analysis are known circadian clock genes showing 
differential expression during sleep and wake (Clock, Bmal, Per1, and Per2), and 
Homer1 which is associated with homeostatic regulation of sleep. Two recently reported 
genes Sik3 and Nalcn that regulate non-rapid eye movement (NREM) and rapid eye 
movement (REM) sleep were also included in the network analysis. Gene networks for 
each of aforementioned genes in combination of our candidate genes was created and the 
nearest neighbors were selected. Each of our candidate genes was assessed for the 
number of previously known genes it interacted with (Supplementary Table A.3). Kcnh3 
was found to interact with all four circadian genes. Cacna2d3 also had four interactions 
with Per1, Clock, Bmal1, and Nalcn. Two interactions were observed for Prom1 (with 
Per2 and Clock), Tpgs2 (with Clock and Bmal1/Arntl), and Myo3a (with Bmal1/Arntl and 
Nalcn) (Figure 6). 
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Figure 2. 7.: Gene networks predicted by GeneMANIA 
Gene networks were created for previously known circadian and sleep related genes 
: A. Per1, B. Per2, C. Clock, D. Bmal1/Arntl, E. Homer1, F. Sik3, G. Nalcn. These 
networks are based on genetic interactions with each node representing single gene, 
and the edges represent physical associations, shared protein domains, co-expression, 
co-localization and their participation in the shared pathways for the candidate genes 
of interest. 
 
Phenotype associations with IMPC database 
Given that sleep is a complex trait and almost a third of the genes being studied in this 
analysis affect sleep, pleiotropy needs to be considered. Abundant pleiotropy has been 
reported for complex traits (Sivakumaran, Agakov et al. 2011). Some of the potential 
sleep regulating genes identified in our study can be broadly categorized into 
transcription factors (Pitx3, Foxo3), immune system related (Ccl26, Vsig4), membrane 
transporters (Slc8b1, Slc46a3) ion channels (Kcnh3, Cacna2d3), neurotransmitters 
receptors (Htr3b, Htr1f, Htr1d), signal transduction (Ppp1r9b, Rab27b, Ap4e1), and 
A B C 
D E F G 
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metabolism (Ghrhr). A wide variety of genes belonging to these functional categories 
have been previously implicated in influencing sleep parameters. Furthermore, these 
categories are likely not exhaustive. Several of these genes have brain-associated 
functions such as myelin formation, neuronal differentiation, synaptic transmission, 
neuronal signal transduction and yet for many others such as Adck2 and Zfp961, there is 
little information available in the literature. None of the target genes, except for Ghrhr 
and Pitx3, have been previously implicated in sleep regulation to the best of our 
knowledge. With a multitude of phenotypes and rich data in the KOMP2 pipeline, cross 
trait analysis is a logical approach to understanding the effects of pleiotropy in this study. 
With a goal of studying what other phenotypes are observed for these genotypes in 
addition to sleep, phenotype data for all 122 candidate genes was collected and analyzed. 
In IMPC gene-phenotype associations, the phenotypes are reported as mammalian 
phenotype (MP) ontology terms. These are the phenotypes that the genes were found to 
be associated with based on the observations from assays and statistical analysis. Our 
candidate genotypes had 550 associations with 146 unique MP terms. Among the MP 
terms that showed high associations with genes, “abnormal sleep behavior” had 37 
followed by “abnormal behavioral response to light” with 23, “decreased circulating 
glucose level” with 22, “decreased total body fat amount” with 20, “abnormal behavior” 
with 16, and “hyperactivity”, “abnormal bone structure”, and “decreased bone mineral 
content” with 14 genes each. When considered in terms of phenotype ontologies, more 
than half of the 550 associations observed belonged to either behavioral/neurological 
phenotype (167 associations) or homeostasis/metabolism phenotype (117 associations). 
These were followed by hematopoietic system phenotype with 65, growth/size/body 
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region phenotype with 45, skeleton phenotype with 40, cardiovascular system phenotype 
with 30, adipose tissue phenotype with 20, and vision/eye phenotype with 16 associations 
(Supplementary Table A.5, A.6). 
 
Functional annotation of candidate genes 
With the goal comparing our candidate genes with pre-existing functional genomic data, 
Geneweaver software system (Bubier, Langston et al. 2017) was used. Geneweaver 
contains a database and a suite of tools that enable cross species and cross platform 
comparison of data from multiple genomic experiments. The utility of the database for us 
lies in the fact that it provides data in the form of gene lists and computational tools to 
perform analysis that help in identifying genes that have been implicated previously in 
the phenotype of user’s interest. By entering the keyword “sleep” as the search term, we 
were able to identify 26 genesets of interest from mouse and human. Using Jaccard 
Similarity Tool for pairwise comparisons, 10 genesets were identified that contained one 
or more of candidate genes we identified through our analysis. Six datasets that are 
“Sleep Disorders”, “Sleep Stages”, “Sleep Deprivation”, “Abnormal Sleep Pattern”, 
“REM Sleep”, and “Abnormal frequency of paradoxical sleep” contained only one gene 
that was the Growth Hormone Releasing Hormone Receptor (Ghrhr). The other 4 
genesets were QTL data for Dps (Delta power in slow wave sleep), and Rapid Eye 
Movement (REM) Sleep. Tmem151b, Tubb4a, Cfb, and Pfdn6 were in the QTL region 
for Dps3 on chromosome 16, and Tppp in Dps1 QTL on chromosome 13. Galnt12 and 
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Dcaf10 were in RemSlp1 QTL on chromosome 4, and Htr1f, Igsf11, and Gpr156 
RemSlp3 QTL on chromosome 16 (Supplementary Figure A.2).       
 
Discussion 
We have reported here the results from a large-scale phenotyping study that 
systematically assesses sleep in knockout mice. With sleep wake recordings from more 
than 6000 mice, consisting of more than 1800 controls and 343 gene knockouts, the 
KOMP2 pipeline at The Jackson Laboratory has generated a wealth of information-rich 
gene centric data that is unprecedented in sleep research. Through our analysis, we have 
been able to identify sleep related genes that have been previously unknown to influence 
sleep. An experimental design using both sexes, and piezo monitoring system that 
consistently reports multiple sleep variables, has allowed for an in-depth analysis to 
identify genes that affect sleep in one or both sexes and during specific times of day. We 
found a considerably high hit rate with nearly a third (35%) of gene knockouts tested 
identified as candidate genes related to sleep behavior. This is perhaps not surprising 
given the dramatic changes in brain physiology and function that occur with sleep and 
wake transitions, and further suggests a potential to uncover many as yet unappreciated 
pathways affecting sleep. Although the purpose and functions of sleep are still unclear, 
we know that sleep is an essential physiological process and that even modest reductions 
in sleep have substantial effects on health and cognitive functions (Shaw and Franken 
2003, Durmer and Dinges 2005, Cohen, Doyle et al. 2009, Cespedes, Bhupathiraju et al. 
2016).  
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We identified several genes that had significant effect on sleep only during a 
specific circadian phase. Pitx3 (Paired like homeodomain transcription factor 3), Bzw2 
(Basic Leucine Zipper W2 Domains 2), and Ccl26 (Chemokine (C-C motif) ligand 26) 
affect sleep durations only during the light phase, and Vsig4 (V-set and immunoglobulin 
domain containing 4), and Cbln3 (Cerebellin 3) during dark phase. Similarly, Pitx3, 
Myh1 (Myosin, heavy polypeptide 1), and Tmem136 (Transmembrane protein 136) 
affect bout lengths only during light phase, and Myo3b (Myosin IIIB), and Rnf10 (Ring 
finger protein 10) during dark phase. Most notable among these is the Pitx3 gene that 
affects both sleep percent and bout length only during light phase. Although little is 
known about the role of Pitx3 and sleep, Derwinska et al have reported that a hemizygous 
deletion on chromosome 10 involving Pitx3 resulted in sleep disturbances beginning 
early childhood in a Caucasian boy (Derwinska, Mierzewska et al. 2012). In addition, 
Pitx3 is well known for its role in regulating lens development and is therefore associated 
with ocular abnormalities as seen in a range of animals including xenopus, zebrafish, 
humans as well as mice where its deficiency is reflected as a form of aphakia 
(Khosrowshahian, Wolanski et al. 2005, Shi, Bosenko et al. 2005, Huang and He 2010). 
In the KOMP2 pipeline, in addition to sleep, Pitx3 is associated with a multitude of 
phenotypes including vision/eye, neurological/behavior, growth/size, 
homeostasis/metabolism, cardiovascular and skeleton. The Pitx3 KO mice have 
anophthalmia or absence of eyes. In mice, Pitx3 is also thought to be essential in 
development of dopaminergic neurons in Substantia Nigra (SN). Besides SN, Pitx3 is 
also expressed in Ventral Tegmental area (VTA)  Reviewed by (Li, Dani et al. 2009). Not 
only these regions are associated with reward, addiction and movement, they also play an 
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important role in sleep and alertness reviewed by (Nishino 2013). Pitx3 is the genotype 
that has the most significant reduction in sleep percent and bout lengths. These low 
numbers cannot be attributed to blindness since there is no evidence of effects on sleep 
duration caused by blindness. There might be sleep difficulties caused by circadian 
disorders like non-24 in unsighted individuals, but that does not necessarily translate to 
lower sleep durations (Weber, Cary et al. 1980). Another interesting aspect is that 16 
sleep related candidate genotypes, including Pitx3, Cbln3, Hsd17b1, and Rnf10, have a 
vision/eye phenotype. These genotypes do not suffer from anopthalmia like Pitx3 mice, 
but have been associated with several other eye phenotypes. These include ‘abnormal 
retina morphology’, ‘abnormal retinal pigmentation’, ‘persistence of hyaloid vascular 
system’, ‘abnormal eyelid aperture’, ‘impaired pupillary reflex’, ‘mydriasis’, ‘abnormal 
lens morphology’, ‘decreased cornea thickness’, and ‘fused cornea and lens’ 
(Supplementary Table A.5). That makes it important to further investigate the role of eye 
morphology in maintenance of sleep architecture.  
Along with Pitx3, Ppp1r9b and Ap4e1 are the candidate genes that were found to 
be significant for both sleep percent and bout length. Ppp1r9b affects both sleep percent 
and bout lengths over 24 hours, light phase and dark phase. Ppp1r9b is the Protein 
Phosphatase 1 Regulatory Subunit 9B (or Neurabin II or Spinophilin), and as the name 
indicates is a regulatory subunit of protein phosphatase (PP1). It is a protein highly 
enriched in dendritic spines (Feng, Yan et al. 2000). Sleep is reported to promote 
formation of dendritic spines for memory consolidation (Yang, Lai et al. 2014). In 
addition, PP1 regulates AMPA channels that are believed to play a role in synaptic 
plasticity, and learning and memory (reviewed in (Prince and Abel 2013). Further, 
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Ppp1r9b is one of the substrates of GSK3B (Glycogen Synthase Kinase 3 Beta), which is 
a crucial circadian clock regulator (Kaasik, Kivimae et al. 2013). Casein Kinase I 
enzymes have been shown to play a critical role in regulating clock genes such as Per2, 
and Ppp1r9b may dephosphorylate some of these same sites and work in opposition 
(Fukuyama 2003 and Padiath 2005). There is increasing evidence that clock genes not 
only influence circadian aspects of sleep and wake, but are fundamentally tied to sleep 
homeostasis as well, which appears to be altered in the Ppp1r9b knockout mice (Franken, 
Thomason et al. 2007, Franken 2013). Ap4e1 was found to be statistically significant for 
24 hours, light phase and dark phase for bout length, and sleep percent over 24 hours. It 
codes for the Epsilon subunit 1 of Adaptor Protein (AP) 4 complex that is involved in 
vesicle trafficking. Ap4e1 has been associated with Cerebral Palsy, and mutations in 
humans have been known to cause intellectual disabilities, of which abnormal sleep 
behavior is one of the symptoms (Moreno-De-Luca, Helmers et al. 2011). Like Pitx3, 
Ap4e1 is associated with multiple additional aberrant phenotypes observed in the KOMP2 
pipeline (Supplementary Table A.6) , and is also found to be within the QTL Cplaq15 
(Circadian Period of Locomotor Activity 15) (Hofstetter, Trofatter et al. 2003).  
Another KO that showed significant changes in sleep-wake traits is Kcnh3 
(Kv12.2) a subunit of potassium channels that regulate neuronal excitability. Kcnh3 KO 
mice have shorter sleep duration in the light phase, and in gene network analysis, was 
found to interact with Per1, Per2, Clock and Bmal1 through co-expression. A similar but 
less pronounced reduction was also seen in Kcnh3 heterozygous mice (data not included). 
Its overexpression has been associated with deficits in learning, and its ablation with 
enhanced cognitive functions (spatial and working memory), hippocampal 
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hyperexcitability and spontaneous seizures (Miyake, Takahashi et al. 2009, Zhang, 
Bertaso et al. 2010). Many other Kv channels are known to modulate sleep-wake. A well-
known example is Shaker in drosophila (Cirelli, Bushey et al. 2005). Flies mutant for the 
Shaker gene have reduced sleep and are short sleepers. In Kcnc1, Kcnc3, Kcnc1/3 and 
Kv1.2 KO mice less NREM sleep has been observed, with a similar magnitude to sleep 
phenotypes observed for Kcnh3 reported here (Rechtschaffen 1998, Cirelli 2009). Hence, 
our study identifies and adds another novel potassium channel associated gene that 
affects sleep. Lack of certain K channels may reduce the resting membrane potential of 
neurons, leading to increased firing, and reduced sleep. While this would occur in both 
inhibitory and excitatory circuits, the net effect is presumably increased excitation. 
Recently, Ding et al (Ding, O'Donnell et al. 2016) has shown that reduction seen in brain 
extracellular potassium ion levels is associated with sleep and anesthetized mice 
supporting this hypothesis.  
Several genes were found to affect breath rate. Majority of these genes affected 
breath rate only as is the case with Tppp (p25 alpha/p24) mice, which had shorter breath 
rate as compared to control mice.  It has been suggested that Tppp, a tubulin-binding 
protein plays an important role in oligodendrocyte differentiation (Lehotzky, Lau et al. 
2010). In addition, Tppp also functions as a glycogen synthase kinase 3 inhibitor (Martin, 
Vazquez et al. 2002). We don’t know yet if breath rate regulating mechanisms are in any 
way associated with other brain functions or sleep-related pathways, but the ability to 
assess breathing should provide additional variables of interest to the larger efforts to 
understand the multiple roles of all protein coding genes.   
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Sex differences were seen for many of the KO lines as well as in B6NJ controls 
throughout our study. Previous studies in mice and humans also report similar sex 
differences in sleep and circadian rhythms, although with relatively small sample sizes. 
Sex differences in sleep have also been observed in BL6J mice for baseline sleep 
parameters such as REM and NREM sleep, with lower values observed in female mice 
(Koehl, Battle et al. 2006, Paul, Dugovic et al. 2006). Sex differences observed in human 
studies have generally been small, but include higher EEG power density in women 
(Carrier, Land et al. 2001). EEG profiles in primary insomnia patients also show sex 
differences (Buysse, Germain et al. 2008). Sex hormones are thought be one of the 
contributing factors for these differences (Collop, Adkins et al. 2004, Krishnan and 
Collop 2006, Pavlova and Sheikh 2011). In addition to small but significant sex 
differences in our control mice, several genotypes had highly significant sleep trait 
differences for a specific sex. KO strains in which sex differences were found might be 
helpful in identifying causes for the intriguing sexual dimorphism seen in sleep behavior, 
such as those in which female mice sleep less than males. In our data, the majority of 
significant findings are sex specific, suggesting at least some biochemical differences in 
female vs. male sleep regulation. 
There are some limitations to this study. The current analysis software does not 
distinguish REM sleep from NREM sleep, however, an algorithm to distinguish these 
sleep states from the piezoelectric recordings is in development and will be utilized in 
future studies once it has had sufficient validation. The premise for the development of 
this algorithm is based on differences in breathing rhythm during REM and NREM sleep. 
Based on our analysis of gene set similarity with REM sleep QTLs and interactions 
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within networks for Sik3 and Nalcn, we are in a position to propose 16 putative 
candidates for REM/NREM sleep. Cacna2d3 (a calcium channel protein) is an interesting 
candidate since it interacts with Nalcn along with circadian Per1, Clock and Bmal1 
genes. Five of these genes including Stx16, Tppp, Rab36, Dcaf10, and Htr1f also 
significantly affect breath rate during sleep and should be considered first in line for 
future studies. Based on similar evidence from Homer1 gene network and Dps QTLs, we 
have also been able to propose 9 novel candidate genes for homeostatic regulation of 
sleep. Here again, Tppp is a key candidate gene since it interacts with Homer1 in co-
expression network, and is also a part of Dps1 QTL.    
Although we were able to detect many novel genes, the extensive filtering of 
sleep signals used in our study most likely excluded genes affecting sleep in subtle ways. 
Genes involved in sleep that have extensive redundancy or compensatory mechanisms in 
place to mask the effect of a gene ablation would also be missed. Finally, the knockout 
method is in general limited by the fact that a gene is ablated in all tissues, so KO of 
essential genes that may in fact be involved in sleep result in a non-viable animal, 
preventing sleep phenotyping. However, utilization of the conditional allele obtained 
from these KOs in the future may overcome this limitation.  It is also unclear to what 
extent any of the sleep alterations from gene ablation are due to direct or indirect effects 
of the gene in question. These questions may be partially addressed by examining the 
multiple phenotypes for each knockout, and can be pursued in other ways for the most 
interesting cases. There is no reason to believe that there are any genes whose sole 
functions are related to sleep, as even the so-called core circadian clock genes are 
pleiotropic (Kyriacou and Hastings 2010, Rosenwasser 2010). 
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Our study demonstrates the utility of rapid-non-invasive sleep phenotyping in 
high throughput mouse screens. This initial set of approximately 350 genes was not 
selected to have sleep phenotypes and yet a high percentage were found to have altered 
sleep phenotypes, and of a magnitude as large as any that have been selected specifically 
for sleep studies over the past 25 years (Cirelli 2009). This supports the utility of an 
unbiased selection and phenotyping for mouse knockouts, especially given that a majority 
of genes are not well understood. Unlike most individual studies of KO mice that 
examine genes predicted to influence a trait of interest, the IMPC/KOMP2 is a 
comprehensive, unbiased approach, having examined more than 2000 genes to date, and 
thus holds potential for detecting and identifying unexpected and pleiotropic effects of 
the knocked out genes (Brown and Moore 2012).With fewer than 350 KOs analyzed to 
date, we demonstrate the potential of this large scale effort to find novel sleep phenotypes 
for a significant percentage of coding genes.  
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CHAPTER 3 
Ensemble approach to identify phenotype predictors for sleep behavior in KOMP2 
 
Background 
Identifying key candidate genes for a trait is important since they can help us 
identify and understand underlying pathways and biochemical mechanisms. The reverse 
genetics approach employed in KOMP2 is a useful resource to understand as to which 
genes affect a specific phenotype. But it is also a great resource to study the data from a 
phenotypic standpoint. In the previous analysis to perform gene-phenotype associations 
between sleep related piezo variables and other phenotypes for genes that were 
significant, we performed a natural word processing to determine the frequency at which 
the mammalian phenotype (MP) ontology terms appeared for those genes. The analysis 
provided key insights including the fact that that a majority of genes significant for sleep 
related variables were also associated with behavioral/neurological phenotype ontology 
terms. Additionally, ontology terms for homeostasis/metabolism phenotypes also 
appeared with high frequency. We previously mentioned that sleep phenotyping is unique 
to the KOMP2 pipeline at The Jackson Laboratory (also called JAX pipeline), and it is 
consistently done at the age of 15 weeks for each mouse. It means that there are data 
available for a multitude of phenotypes from the previous 14 weeks before a mouse 
enters the sleep studies and 3 weeks after that. In this part of the project, the driving 
question is how these phenotypes are affecting sleep. In other words, can we predict an 
abnormal sleep behavior based on the data available from other phenotypical assays 
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performed in the KOMP2 pipeline, some of which may be useful throughout the larger 
IMPC. 
The International Mouse Phenotyping Consortium (IMPC) website 
(www.mousephenotype.org) is a repository of all data generated from KOMP2  and 
related phenotyping pipelines from centers across the world. There is a user interface that 
allows individual gene or phenotype level searches. Batch query is an option, and the 
website also provides several tools and visualizations for statistical analysis including all 
the documentation. Simple and batch querying is effective for basic data searches, but not 
suitable for complex queries where the output can be large, with several thousand or 
millions of data points. IMPC also provides APIs for data dissemination. API stands for 
Application Programming Interface which is a set of routines and protocols for 
developing software applications, and allows for two software programs to communicate 
with each other.  IMPC APIs allow for remote computers to interact with their servers 
and gather data through customized queries. IMPC uses RESTful API based on 
representational state transfer (REST) technology that allows for gathering data through 
HTTP (Hypertext Transfer Protocol). IMPC REST APIs can be queried through Apache 
Solr, a Java based open source enterprise search platform that has a variety of search 
features and runs as a standalone full text search server. The Solr queries can be run 
standalone, or embedded inside another programming environment like R. The data is 
gathered in JSON format that can be transferred through the web and is language 
independent. In simple terms, this allows for any user with an internet access to connect 
to IMPC servers and gather data according to their requirements. Currently IMPC 
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provides four APIs that are for genotype-phenotype, statistical results, observation, and 
images. 
 Data science is an emerging interdisciplinary field formed from a combination of 
statistics, data mining, predictive analytics and machine learning with the goal of 
extracting knowledge and information from varied sources and forms of data. With the 
advances in computing, there has been an explosion of data that has resulted in datasets 
that are large in size and complex in formats and structure. These data-sets and the 
multiple of approaches to utilize and extract useful information is often referred to as Big 
Data, and is another emerging field. There has been a growing interest in applications of 
big data analytic approaches for sleep studies(Dean, Goldberger et al. 2016, Bianchi, 
Russo et al. 2017, Li, Cui et al. 2017). The IMPC currently houses phenotype data from 
more than a hundred thousand mice with millions of data points, and that is just the 
number of observations from phenotype assays. The observation and results from each 
phenotype has its own structure and format depending on the technique being used to 
gather the data.  This complexity is often difficult for traditional processing applications, 
but newer Data science approaches, geared towards big data analytics, are equipped to 
deal with data of this size and complexity. 
Several statistical approaches are available to perform multivariate analysis on 
high dimensional data. Multivariate multiple regression modeling helps to relate the 
dependent variable to several independent variables. By establishing a pattern of 
relationships between independent and dependent variables, the response can be 
estimated and the accuracy of the model is assessed. Classification and Regression Trees 
(CART), also called Decision Trees is another multivariate approach for high 
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dimensional data that produces a result in the form of a flowchart (Rokach and Maimon 
2008). The data is split into branch-like segments with the root node at the top and 
branches below it. Modeling approaches depending on results from a single run of an 
algorithm are prone to confounding results because of overshadowing of one strong 
predictor over all others. Ensemble methods are general terms describing approaches that 
involve the use of multiple algorithms to gain better predictive performance (Opitz and 
Maclin 1999, Polikar 2006). Random Forest is one such approach that involves an 
ensemble of decision trees developed from randomly selected subsets of observations 
(Zhang, Ma et al. 2012). This helps in examining the contribution of predictors that might 
not have been significant in the presence of other strong predictor variables. Another 
advantage is that the random forests provide values for conditional permutation accuracy 
that helps in assessing conditional variables importance. Bootstrap aggregation (Bagging) 
takes place while running the algorithm. This means that a random subset of the data is 
used as a training dataset to develop a tree while the rest of the data remains out of the 
bag (oob) and acts as a test dataset. The accuracy of the model is assessed at each step on 
this test data and measured through out of bag (oob) error which is the mean prediction 
error on each training sample. The random forests have been shown to improve accuracy 
as compared to a single decision tree on its own.  
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Methods 
Data Collection 
Each mouse that enters the phenotyping pipeline in KOMP2 is assigned a unique 
mouse id that makes it possible to track the data being collected throughout its life cycle 
in the pipeline. Our goal was to collect for all phenotypes from mice who underwent 
sleep phenotyping at The Jackson Laboratory, also referred to as the JAX pipeline. We 
used IMPC Observation API to query the database for mice from the JAX KOMP2 
pipeline. The total datapoints in IMPC are 33.07 million, with 2.49 million from JAX 
pipeline. We then queried the database for mouse ids of mice that underwent “Sleep-
Wake” procedure. We obtained 65,702 observations for sleep related variables from 
4,406 mice (1.43 million observations). We then gathered all the phenotype observation 
data available for these 4,406 mice in the JAX pipeline (Figure 3.1). 
 
Figure3. 1.: Schematic of data collection procedure through IMPC API 
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Data Scrubbing and Imputation 
IMPC data releases have already undergone substantial quality checks 
and validation so there was no need for parsing. Data contained 207 
phenotype variables from 4,406 mice. However, the data we acquired had a 
substantial number of missing values. 135 variables with more than 50% 
missing data were dropped from the analysis, leaving 72 variables that could 
be included in further analysis (Table 3.1). Multiple imputation was carried 
out through Bayesian bootstrapping predictive mean matching. 
Parameter Procedure Week 
Locomotor activity Combined SHIRPA and Dysmorphology 8 
Forelimb and hindlimb grip strength 
normalized against body weight Grip Strength 8 
Forelimb grip strength normalized 
against body weight Grip Strength 8 
Center average speed Open Field 8 
Center distance travelled Open Field 8 
Center permanence time Open Field 8 
Distance traveled Open Field 8 
Total distance traveled Open Field 8 
Percentage center time Open Field 8 
Periphery average speed Open Field 8 
Periphery distance travelled Open Field 8 
Periphery permanence time Open Field 8 
Whole arena average speed Open Field 8 
Whole arena resting time Open Field 8 
Total holepokes Hole-board Exploration 9 
Dark side time spent Light-Dark Test 9 
Latency to first transition into dark Light-Dark Test 9 
Percent time in dark Light-Dark Test 9 
Percent time in light Light-Dark Test 9 
Side changes Light-Dark Test 9 
Time mobile dark side Light-Dark Test 9 
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Time mobile light side Light-Dark Test 9 
% Pre Pulse Inhibition PP1 Acoustic Startle and Prepulse Inhibition (PPI) 10 
% Pre Pulse Inhibition PP2 Acoustic Startle and Prepulse Inhibition (PPI) 10 
% Pre Pulse Inhibition PP3 Acoustic Startle and Prepulse Inhibition (PPI) 10 
Response amplitude BN Acoustic Startle and Prepulse Inhibition (PPI) 10 
Response amplitude PP1 Acoustic Startle and Prepulse Inhibition (PPI) 10 
Response amplitude PP1_S Acoustic Startle and Prepulse Inhibition (PPI) 10 
Response amplitude PP2 Acoustic Startle and Prepulse Inhibition (PPI) 10 
Response amplitude PP2_S Acoustic Startle and Prepulse Inhibition (PPI) 10 
Response amplitude PP3 Acoustic Startle and Prepulse Inhibition (PPI) 10 
Response amplitude PP3_S Acoustic Startle and Prepulse Inhibition (PPI) 10 
Response amplitude S Acoustic Startle and Prepulse Inhibition (PPI) 10 
CV Electrocardiogram (ECG) 11 
Mean R amplitude Electrocardiogram (ECG) 11 
Mean SR amplitude Electrocardiogram (ECG) 11 
Number of Signals Electrocardiogram (ECG) 11 
pNN5(6>ms) Electrocardiogram (ECG) 11 
PQ Electrocardiogram (ECG) 11 
PR Electrocardiogram (ECG) 11 
QRS Electrocardiogram (ECG) 11 
QTc Electrocardiogram (ECG) 11 
QTc dispersion Electrocardiogram (ECG) 11 
rmSSD Electrocardiogram (ECG) 11 
RR Electrocardiogram (ECG) 11 
ST Electrocardiogram (ECG) 11 
HR (Heart Rate) Electrocardiogram (ECG) 12 
HRV (Heart Rate Variability) Electrocardiogram (ECG) 12 
Area under glucose response curve Intraperitoneal glucose tolerance test (IPGTT) 12 
Blood glucose concentration Intraperitoneal glucose tolerance test (IPGTT) 12 
Fasted blood glucose concentration Intraperitoneal glucose tolerance test (IPGTT) 12 
Initial response to glucose challenge Intraperitoneal glucose tolerance test (IPGTT) 12 
BMC/body weight Body Composition (DEXA lean/fat) 14 
Body length Body Composition (DEXA lean/fat) 14 
Body weight Body Composition (DEXA lean/fat) 14 
Body weight curve Body Composition (DEXA lean/fat) 14 
Bone Area (BMC/BMD) Body Composition (DEXA lean/fat) 14 
Bone mineral content excluding skull Body Composition (DEXA lean/fat) 14 
Bone mineral density excluding skull Body Composition (DEXA lean/fat) 14 
Fat mass Body Composition (DEXA lean/fat) 14 
Fat/body weight Body Composition (DEXA lean/fat) 14 
Lean mass Body Composition (DEXA lean/fat) 14 
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Lean/body weight Body Composition (DEXA lean/fat) 14 
Sleep bout lengths mean Sleep-Wake 15 
Sleep daily percent Sleep-Wake 15 
6 kHz evoked ABR Threshold Auditory Brain Stem Response (ABR) 16 
12 kHz evoked ABR Threshold Auditory Brain Stem Response (ABR) 16 
18 kHz evoked ABR Threshold Auditory Brain Stem Response (ABR) 16 
24 kHz evoked ABR Threshold Auditory Brain Stem Response (ABR) 16 
30 kHz evoked ABR Threshold Auditory Brain Stem Response (ABR) 16 
Heart weight Heart weight 18 
Table 3. 1.: Variables included in the phenotype predictor analysis. 
These variables had less than 50% missing values in the JAX pipeline and were 
included in the further analysis. 
 
Data modeling 
Data was divided into training and test datasets in 80:20 ratio. Multivariate simple 
linear regression was carried out to identify the phenotypes variables that significantly 
affect sleep. A combination of both forward and backward stepwise regression was 
carried out, followed by backward elimination until all variables in the model were 
significant. This additional backward elimination step was carried out because of 
multicollinearity in the data (Figure 3.2). Relative importance of variables was calculated 
after bootstrapping for 1000 iterations. Regression Trees were built for Daily Sleep 
Percent and similar analysis was carried out for Mean Bout Length variable. In the final 
step, Random Forest regression was performed by building 5000 trees and important 
variables were identified based on percent increase in mean squared error by randomly 
permuting a variable. In addition to that, we also made a baseline model comparing 
original values and mean values for daily sleep percent and mean bout length. Model 
accuracy was assessed for each model by calculating Mean Squared Error (MSE) from 
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original and predicted values. The same training and test datasets were used for all 
models. 
Data analysis was performed in R programming environment. The phenotype 
observation data was collected from IMPC Observation API using package solr 
(Chamberlain 2015). Regression trees were built using rpart package (Therneau, 
Atkinson et al. 2010), and package party was used for plotting the results (Hothorn, 
Hornik et al. 2015). Package randomForest was used to perform Random Forest analysis 
(Liaw and Wiener 2002). 
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Figure 3. 2.: Correlation plot of KOMP2 variables. Blue color represents positive 
correlations and Red represents negative correlations Sizes of the dots are in 
proportion to their values.  
 
Results 
Sleep Daily Percent 
Based on the results from three different data analysis approaches, the ratio of 
bone mineral content to body weight (BMC/BW) is the most significant predictor for 
sleep percent over 24 hours. BMC/BW is followed by fat mass and fat body weight 
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variables in their importance in the regression model (Figure 3.3). In addition to these, 
the random forest model also includes body weight, and lean mass (Figure 3.4). 
Aforementioned variables are from body composition phenotype assessed at 14 weeks of 
age in KOMP2. Body weight curve is also a variable with high importance in random 
forest result. It records the weekly pattern of weight changes from 4th to 16th week in the 
pipeline. Time mobile dark side is a part of Light-Dark Test carried out in 9th week, and 
Mean SR amplitude variable from Electrocardiogram (ECG) in 11th week. The light-dark 
test results are indices of bright space anxiety in mice where more time spent in the dark 
side as compared to control mice is a sign of anxiety. Both of these variables were found 
to be important in both regression and random forest analysis. In the regression model, 
additional variables from Open Field (Total distance traveled, and Periphery distance 
traveled) and Grip Strength measurement (Forelimb and Hindlimb grip strength 
normalized against body weight) were also found to be significant. Decision tree model 
identified three key variables among the ones mentioned above affecting duration of 
sleep with BMC/BW was the root node. Data with SR amplitude values less than 0.76 are 
more likely to have lower sleep durations. It is a variable from electrocardiogram 
procedure, and represents the amplitude between S and R points in the PQRST 
waveforms seen in ECG. Fat mass values higher than 4.24 are more likely to have higher 
sleep percent values (Figure 3.7).  
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Figure3. 3.: Variable importance in multiple regression model for Daily Sleep Percent 
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Figure3. 4.: Variable importance in Random Forest model for Daily Sleep Percent. 
%IncMSE represents the percent increase in mean square error by permuting the 
variable.  
 
Mean Bout Length 
For mean bout length values, the importance of variables differed considerably 
between multiple regression and random forest (Figure 3.5, 3.6). In multiple regression 
model, Whole arena average speed was the variable with highest relative importance, 
followed by Time mobile dark side (Light-Dark test, Week 9), Response Amplitude-PP1 
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S (Acoustic Startle and Prepulse Inhibition, Week 10), and Mean SR Amplitude, and 
Mean R Amplitude (ECG, Week 11). Body Composition variables like fat and lean body 
mass and weight do appear but with numbers much lower than what was seen for sleep 
daily percent. The variable importance in random forest model was much closer to sleep 
percent with BMC/BW being the variable with highest importance followed by Body 
weight, Body weight curve, Lean mass and Fat mass. Area under the glucose response 
curve (Intraperitoneal Glucose Tolerance Test, Week 12) also appeared with high 
importance. The decision tree model for mean bout lengths had Body Weight at the root 
node, with splits at BMD/BW, and Area under glucose response curve. Based on this 
model, mice with body weight lower than 23.37 grams, and BMC/BW more than 0.018 
are more likely to have shorter bout lengths, and mice with weights higher than 23.27 and 
BMC/BW less than 0.018 more likely to have longer mean bout lengths (Figure 3.8). 
 
Figure3. 5.: Variable importance in multiple regression model for Mean Bout Lengths 
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Figure 3. 6.: Variable importance in Random Forest model for Mean Bout Lengths. 
%IncMSE represents the percent increase in mean square error by permuting the 
variable. 
 
Model Comparison 
For both daily sleep percent and mean bout length variables, random forest model 
was found to be most accurate with minimum MSE values. For daily sleep percent 
variable, the baseline model had MSE of 20.56. The multiple regression model was much 
improved with MSE value 17.19. The Decision tree model had MSE of 18.04, though 
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better than baseline but less accurate than the regression model. MSE for random forest 
model was 16.84 which is the lowest among all. Similar trend was seen for mean bout 
length models where all three performed better than the baseline. The baseline model had 
MSE of 7964.65, followed by decision tree (MSE = 6636.99), multiple regression (MSE 
= 6849.84), and random forest (MSE = 6552.71). 
 
Figure 3. 7.: Decision Tree for Sleep Daily Percent 
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Figure 3. 8.: Decision Tree for Mean Bout Length 
 
Discussion 
Predictive modeling was carried out through multiple data models and key 
predictor phenotypes were identified for sleep behavior. Body composition parameters 
were found to be main predictors for both sleep percent and bout length. Data modeling is 
nuanced by several factors that can affect the accuracy and predictive ability of the 
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model. Multicollinearity, distribution and variance are all such factors. We observed 
similar MSE values for multiple regression and random forest models. In an approach 
like ours where the data is divided into training and test subsets, a major limitation with 
linear modeling approaches (i.e. multiple regression) is that a change in the training 
subset might bring about a change in the composition of variables in the model. 
Ensemble approaches, wherein the final model is based on the results from thousands of 
tree models are more robust to aforementioned changes in data. Though there were no 
dramatic changes in MSE values to suggest improvements in the model, but the goal of 
identifying phenotype predictors for sleep behavior was largely accomplished. The 
results from decision tree provide further evidence of the validity of results along with 
insights into how the data for predictors is affecting dependent variable. 
The main predictors for sleep behavior in our analysis: BMC/BW, Body weight, 
Fat mass and Lean mass, are all part of Body Composition phenotype in KOMP2. 
Traditionally, bone mineral content and body composition have treated as separate 
phenotype in studies (Manzoni, Brambilla et al. 1996, Henderson and Madsen 1999), but 
in KOMP2, they are part of the same procedure. Limited literature is available for the role 
of bone mineral content with respect to sleep. A pertinent hypothesis would be the 
possible role of clock genes. Clock genes that maintain rhythmicity of several 
physiological systems by regulating gene expression are present in virtually all cells 
including bone cells (Rosen 2008). Osteoclasts that break down old bone contain Cry1, 
Per1, Per2, and Bmal1, and osteoblasts that make new bone tissue contain Per1, Per2, 
Cry1, Clock, and Bmal1 (Fu, Patel et al. 2005, Fujihara, Kondo et al. 2014). Circadian 
rhythmicity has been seen in the function of osteoblasts and osteoclasts which is 
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identified by expression levels of Bone Turnover Marker genes. The process of bone 
resorption and some bone formation increases through the night and peaks early in the 
morning, with lowest levels in the afternoon (Luchavova, Zikan et al. 2011, Michalska, 
Luchavova et al. 2012). Abnormal sleep behavior has the potential to disrupt this 
rhythmicity and may cause decrease in rates of bone formation (Specker, Binkley et al. 
2007, Rao, Blackwell et al. 2009). Another possibility is that the change in bone mineral 
content might be an indirect effect of body weight. Excessive reduction or gain in body 
weight has been known to affect bone mineral content (Simon, Holmes et al. 1985). 
Moreover, sleep deprivation or abnormal sleep behavior has been associated with obesity 
(Chaput, Despres et al. 2008, Mavanji, Billington et al. 2012). 
Another possible indirect effect on sleep can be postmenopausal bone mineral 
loss caused by cessation of ovarian function. Estrogen replacement therapy (ERT) 
prevents this bone loss and resultant osteoporosis (Lindsay, Hart et al. 1984, Sheldon 
1984). Sleep difficulties also increase in frequency during menopause. These include 
insomnia (Ameratunga, Goldin et al. 2012), breathing irregularities (Saaresranta, Polo-
Kantola et al. 2001), difficulty in maintaining sleep, and hot flashes (Woodward and 
Freedman 1994) . Hot flashes are sudden feeling of intense warmth on face, neck and 
chest sometimes with profuse sweating. Although ERT ablates some of the 
aforementioned sleep difficulties especially hot flashes (Sarti, Chiantera et al. 2005), it 
was not found to affect overall sleep quality (Becerra, Becerra et al. 2016).   
The amount of data generated in KOMP2 is increasing constantly and provides 
unprecedented opportunities to investigate and understand phenotypes. In all phenotyping 
pipelines across the world, 3,328 out of nearly 20,000 mouse genes phenotyped 
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(according to IMPC Data Release 5.0). The data we analyzed represented only 209 
knockout lines that have been phenotyped for sleep behavior in the JAX pipeline. The 
model that we have created and the predictor phenotypes that we have identified can help 
in identifying candidates for sleep behavior based on the data from rest of the centers as 
well. So even if the gene is not a part of JAX pipeline, individual researchers can still 
acquire those gene knockout mice and conduct their own sleep studies. Our results also 
open doors for studying genes previously reported in literature for the phenotypes 
mentioned in this analysis. On a big data scale, it can be conducted by using natural 
language processing algorithms to collate information about genes and phenotypes. 
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CHAPTER 4 
Conclusions        
 
This study utilizes data generated from the KOMP2 project at The Jackson 
Laboratory, a large-scale project intended to phenotype knockout mice in alignment with 
the IMPC. The scale of data used in this report for studying sleep behavior in mice is 
unprecedented in the field. The KOMP2 deals with the dark matter of the genes (i.e. the 
genes that have not been extensively studied). Even in this scenario, genes significant for 
sleep related variables appear at an incredibly high hit rate. This study reports on more 
than 6000 mice representing 343 different gene knockouts, along with over 1800 BL6NJ 
control mice all assessed for sleep and wake as a part of the unique behavioral 
phenotyping pipeline at JAX. Our findings showed altered sleep and wake in many of the 
knockout lines compared to the controls. Many of these strains also exhibit sex 
differences in sleep traits. In all, large number of genes were identified in which targeted 
deletion resulted in high to modest effects on one or more of the observed sleep-wake 
traits.  
A total of 122 genes were identified that significantly affected sleep in KOMP2 
data. Out of these, 55 were found to be significant for individual piezo variables, 81 
genes identified in sex based analysis, 51 in principal component analysis, and 29 in 
outlier analysis. Key genes have been identified that affect overall sleep like Ppp1r9b, 
and genes like Pitx3 that affect sleep only during specific circadian phase. The main 
limitation with a large-scale study like KOMP2 is that the congenital absence of gene 
function cannot provide any information for genes with embryonic lethal phenotype. In 
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such cases, conditional knockout of genes at different stages of development can provide 
better insights into their mechanism and function. Another limitation is the use of a single 
genetic background. Though C57BL/6 has been a robust model system, recent studies 
have shown that strong gene-phenotype interactions can be seen in different mouse 
strains that are in diametrically opposite direction (Sittig, Carbonetto et al. 2016). Since 
the goal of our report is to generalize these findings to humans, it would therefore be 
ideal to examine the effects of the candidate genes on sleep behavior in mice belonging to 
several genetic backgrounds.  However, this is impractical in most cases.  In cases where 
a gene is of sufficient interest, diverse genetic backgrounds could take advantage of the 
Collaborative Cross (CC) inbred strains that are ideal for studying complex behavioral 
traits like sleep (Philip, Sokoloff et al. 2011, Chesler 2014). These populations have been 
developed from an eight-way cross of common laboratory and wild-derived strains which 
translates to a high level of precision and allelic diversity. A combination of conditional 
gene knockouts with CC resources would help in identifying and tracing variations in 
sleep behavior for candidate genes and the underlying neurobiological phenomena.  The 
CC mice, and the associated DO mice (from the same parents) may also display 
“naturally” occurring allelic variations including both gene “knockout” and more subtle 
variations, which may also shed light on the influence of each gene on sleep traits.  The 
DO mice have the disadvantage of each mouse having a unique genotype, that cannot be 
studied in replicate in the present or the future, but also have the advantage of being a 
healthier animal with more normal levels of heterozygosity.   
Breath rate is a supplemental variable from piezo whose role is underplayed in the 
analysis since it is a relatively new measure. It is separate variable in itself that is 
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different from the measures of sleep duration and consolidation. The breath rate can help 
in identifying phenotypes related to obstructive sleep apnea, and REM/NREM sleep. The 
breathing pattern during REM sleep is ataxic or irregular, as compared to the rhythmic 
pattern seen during NREM. Rather than measuring the mean breath rate during whole 
duration of sleep, gathering data in smaller time intervals during subjective night can 
provide insights into the breathing patterns during those periods, thus allowing for better 
differentiation between REM/NREM sleep. The algorithm to carry out such 
differentiation is in the works, the application of which will open avenues to identify 
genes affecting different stages of sleep.  Obstructive sleep apnea (OSA) is a syndrome 
that affects 10 – 17% of US population (Young, Finn et al. 2008, Punjabi, Caffo et al. 
2009). The symptoms are oxygen desaturation, loud snoring, frequent arousals, and 
disruption of sleep, and has been associated with cardiovascular disease (Shahar, 
Whitney et al. 2001, Marin, Carrizo et al. 2005), hypertension (Nieto, Young et al. 2000), 
cognitive impairment, and metabolic abnormalities (Young, Peppard et al. 2002). The 
piezo sleep variables along with breathing rate in combination with results from 
multitude of physiological phenotyping assays make KOMP2 a great resource to further 
our understanding of this disorder. 
Functional annotation of genes identified in our analysis was carried out by cross-
referencing them with the mammalian phenotype terms that they were associated with in 
IMPC. In the field of ontology, sleep has been traditionally treated as a monolithic entity 
that is wither “normal” or “abnormal”. The current mammalian phenotype ontology for 
sleep behavior consists of “NREM sleep pattern”, “paradoxical sleep pattern”, 
“fragmentation of sleep-wake states”, and “narcolepsy”. Only 37 out of 122 genes being 
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reported in current analysis are captured by these ontologies. Though this is much better 
than treating sleep as a single entity, it is still far from covering the complexities of sleep 
behavior.  Now that we have a large amount of sleep data from mice, it is possible to 
include more ontological terms for sleep behavior. To begin with, these would include 
“short sleepers”, “long sleepers”, “abnormal sleep during light phase”, and “abnormal 
sleep during dark phase”.  
The follow up study to identify predictor phenotypes in Chapter 3 showed “Bone 
mineral content divided by body weight” as the most important predictor for sleep 
percent and mean bout lengths over 24 h. In this analysis, I have completely focused on 
phenotypes while taking the genotypes out of the equation. There are a couple of 
advantages with this approach. First, it helps in identifying the predictors for the 
phenotypes of interest. Second, on the more abstract level, it provides a peek into the fine 
tapestry of relationships that exist between phenotypes, the magnitude of which would be 
difficult to study if the focus is solely on the genes.   
The key to any data analysis exercise is to ask prudent questions  and then prepare 
and analyze the data to answer those questions. The results reported in this thesis answers 
several questions regarding a number of genes which appear to influence sleep, that in 
turn may help in gaining a better understanding of the underlying processes governing 
sleep. The data available through KOMP2 continue to increase and the analysis presented 
in this report sets the groundwork for future identification of novel sleep related genes 
and predictor phenotypes that will empower the sleep research community. It is a small 
step forward in understanding of the phenomenon called sleep that has been a mystery, 
and something that a majority of the human race can’t get enough of.  
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APPENDIX 
List of Abbreviations 
ANOVA Analysis of Variance 
API Application Programming Interface 
BMC/BW Bone Mineral Content divided by Body Weight 
CART Classification and Regression Trees 
ECG Electrocardiogram 
EEG/EKG Electroencephalogram 
ERT Estrogen Replacement Therapy 
HTTP Hypertext Transfer Protocol 
IKMC Internation Knockout Mouse Consortium 
IMPC Internation Mouse Phenotyping Consortium 
JAX The Jackson Laboratory 
KOMP Knockout Mouse Project 
KOMP2 Knockout Mouse Phenotyping Program 
MD Mahalanobis Distance 
MSE Mean Squared Error 
PCA Principal Component Analaysis 
PVDF Polyvinylidine Difluoride  
QTL Quantitative Trait Loci 
REST Representational State Transfer  
SCN Suprachiasmatic Nucleus 
TMN Tuberomammillary Nucleus  
VLPO Ventrolateral Preoptic Area  
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Supplementary Tables and Figures 
 
Gene name 
Sleep 
Daily 
Percent 
Sleep 
Percent 
during 
Light 
Phase 
Sleep 
Percent 
during 
Dark 
Phase 
Bout 
Lengths 
Mean 
Light 
phase 
bout 
lengths 
mean 
Dark 
phase 
bout 
lengths 
mean 
Breath 
Rate 
1700016K19Rik 1 1 1 1 1 1 1 
4921509C19Rik 1 0.195 1 1 1 1 1 
A1cf 1 1 1 1 1 1 1 
Abca16 1 1 1 1 1 1 1 
Abca7 1 1 1 1 1 1 1 
Abcg2 1 1 1 1 1 1 1 
Acap1 1 1 1 1 1 1 1 
Acsf2 1 1 1 0.882 1 1 0 
Acsm2 1 1 1 1 1 1 1 
Actrt3 1 0.995 1 1 1 1 1 
Adad2 1 1 1 1 1 1 1 
Adck2 1 0.279 1 1 0.012 1 0.053 
Adck5 1 1 1 1 1 1 1 
Adgrb2 1 0.468 1 1 1 1 1 
Adora2b 1 1 1 1 1 1 1 
Ahrr 1 1 1 1 1 1 1 
AI464131 1 1 1 1 1 1 1 
Ajap1 1 0.479 1 1 1 0.499 0.166 
Akap11 1 0.984 1 1 1 1 1 
Akip1 1 1 1 1 1 1 1 
Akr1b8 1 0.991 1 1 1 1 1 
Akr1d1 1 1 1 1 1 1 1 
Ap4e1 0.002 0.082 0.416 0.001 0.009 0.009 0.999 
Arf2 1 0.981 1 1 0.063 1 1 
Arhgef10 1 1 1 1 1 1 1 
Arpc5l 1 1 1 1 1 1 1 
Arrb1 1 1 0.7 1 1 1 0.831 
Arrb2 0.305 1 0.11 1 0.026 1 1 
Arrdc1 1 1 1 1 1 1 0.996 
Arsk 1 1 1 1 1 1 1 
Asb10 1 1 1 1 1 1 1 
Bbox1 1 1 1 1 1 1 1 
BC030499 0.891 0.716 1 1 1 1 0.073 
BC100451 1 0.517 1 1 1 1 0.994 
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Bex4 1 0.042 1 0.796 1 0.025 0.855 
Bhlhe40 1 1 1 1 1 1 1 
Bmp2k 1 1 1 1 1 0.995 1 
Btg2 1 1 1 1 1 1 1 
Bzw2 0.013 0.003 1 1 0.838 1 0.124 
C1qa 1 1 1 1 0.997 1 0 
C1qb 1 1 1 1 1 1 0.243 
C1qtnf5 1 1 1 1 1 1 0.166 
C3 1 1 1 1 1 1 0.994 
C9 1 1 1 1 1 1 1 
Cacna2d3 1 1 1 1 1 1 1 
Car12 1 1 1 1 1 1 1 
Carf 1 0.603 1 1 1 0.985 0.001 
Cast 1 1 1 0.836 0.907 1 1 
Cbln3 0.001 1 0.001 1 1 1 0 
Ccdc120 1 1 1 1 1 1 1 
Ccl26 0.003 0.009 0.92 1 0.906 1 1 
Cd33 1 1 1 1 1 1 1 
Cd84 0.823 0.81 1 1 1 1 0.015 
Cdc20 0.008 0.941 0.125 1 1 0.314 1 
Cdh4 1 1 1 1 1 1 1 
Cdk15 0.081 0.075 1 1 1 1 0.686 
Cdk19 1 0.997 1 1 1 1 1 
Ceacam16 0.82 1 1 1 1 1 1 
Cers5 0.839 0.293 1 1 1 1 0.054 
Ces4a 1 1 1 1 1 1 0.154 
Cfb 1 0.981 1 1 1 1 0.012 
Chek2 1 1 1 1 1 1 1 
Chn1 0.119 0.464 0.999 1 1 1 1 
Cited4 1 1 1 1 1 1 1 
Cldn13 1 0.808 1 1 0.137 1 0.998 
Cldn19 1 1 1 1 1 1 1 
Clvs1 1 1 1 1 1 1 0.989 
Cml2 1 1 1 1 1 1 1 
Col18a1 1 0.808 1 1 1 1 1 
Cp 1 0.991 1 1 1 1 1 
Cpb1 1 0.002 1 1 0.997 0.922 0.977 
Crym 1 1 1 1 1 1 0.017 
Cyb5d1 1 0.989 1 1 1 1 1 
Cyb5d2 1 1 1 1 1 1 1 
Dcaf10 1 1 1 0.165 1 0.069 0 
Dennd2d 1 1 1 1 1 1 0.954 
Dixdc1 1 1 1 1 1 1 1 
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Dnaja4 1 0.001 1 1 0.628 1 0 
Dnajb3 1 1 1 1 1 1 1 
Dnajb7 1 1 1 1 1 1 0.89 
Dnajc14 1 0.842 0.44 1 1 1 0.999 
Dnajc28 1 1 1 1 1 1 1 
Dnajc5g 1 1 1 1 0.999 1 0.746 
Dnajc7 1 1 1 0.753 1 0.924 0.071 
Dnase1l2 1 1 1 1 1 1 1 
Dntt 1 1 1 1 1 1 1 
Dpf1 1 1 1 0.996 1 1 1 
Efna4 1 1 1 1 1 1 1 
Elk1 1 1 1 1 1 1 1 
Enox1 1 0.975 1 1 1 1 1 
Eogt 1 0.034 1 1 0.806 1 1 
Epb4.1l4a 1 1 1 1 1 1 1 
Epgn 1 0.008 1 1 1 1 0.426 
Epha10 1 0.069 1 1 1 1 0.971 
Ermp1 1 1 1 1 0.023 1 1 
Espnl 1 1 1 1 1 1 1 
Esrra 1 1 1 1 1 1 1 
F2rl1 1 1 1 1 1 1 1 
Fam161a 1 1 1 1 1 1 0.307 
Fam186b 0.997 1 1 0.247 0.08 0.997 1 
Fam217b 1 1 1 1 1 1 1 
Far2 0.824 0.911 1 1 1 1 0.983 
Fastkd5 1 0.999 1 1 1 1 1 
Fdxacb1 1 0.993 1 1 1 1 0.239 
Fndc4 1 1 1 1 1 1 1 
Foxi2 1 0.162 1 1 1 1 0.105 
Foxo3 0.998 0.015 1 1 0.994 1 1 
Foxred2 1 1 1 1 1 1 1 
Galnt12 1 1 1 1 1 1 1 
Gfod1 1 1 1 1 1 1 1 
Ghrhr 1 1 0.879 0.986 1 0.019 1 
Ghsr 1 0.993 1 1 1 1 1 
Gimap6 0.989 0.178 1 1 1 0.905 0.996 
Gimap8 1 1 1 1 1 1 1 
Gipc3 1 0.204 1 1 0.215 1 1 
Gjd4 0.993 0.047 1 1 1 0.999 0.915 
Glycam1 1 1 1 1 1 0.931 1 
Gpnmb 1 1 1 1 1 1 1 
Gpr142 1 1 1 0.997 1 0.598 1 
Gpr156 0.996 1 1 1 1 1 1 
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Gpr183 1 0.978 1 1 1 1 1 
Gpr19 1 1 1 1 1 1 1 
H1fx 1 1 1 1 0.999 0.393 1 
Hc 1 1 1 1 1 1 1 
Hdac10 1 1 1 1 1 1 1 
Hemgn 1 1 1 0.97 1 0.11 1 
Heyl 1 1 0.999 1 1 1 1 
Hfe2 1 1 1 1 1 1 1 
Hsd17b1 1 0 0.998 0 0 1 1 
Hsd17b11 1 0.679 1 1 1 1 0.601 
Hsf2 1 1 1 1 1 1 1 
Hsf4 1 1 1 1 1 1 1 
Hspb1 1 1 1 1 1 0.977 1 
Hspb2 1 1 1 1 1 1 1 
Hspb3 1 1 1 0.991 1 1 1 
Htr1a 1 0.919 1 1 1 1 1 
Htr1d 1 1 1 1 0.001 1 0.996 
Htr1f 0.965 0.002 1 1 1 1 0.004 
Htr3b 1 0.025 1 1 1 1 1 
Htr7 1 1 1 1 1 1 1 
Hyal3 1 1 1 1 1 1 1 
Ifnk 1 0.999 1 1 1 1 1 
Ifnl3 0.99 0.004 1 1 1 1 0.204 
Igsf11 1 1 0.67 1 1 1 0.233 
Il12rb2 1 0.78 1 1 0.765 1 0.009 
Il24 0.997 1 0.434 0.998 0.761 1 1 
Ipp 1 0.553 1 1 0 1 0.614 
Iqcj 1 1 1 1 1 1 1 
Iqgap2 1 1 1 1 1 1 1 
Irf8 1 1 1 1 1 1 1 
Jam2 1 0.492 1 1 1 1 0.092 
Jmjd8 1 1 1 1 1 1 1 
Kcnh3 1 0.028 1 1 1 0.747 1 
Klk14 1 1 1 1 1 1 1 
Krt77 1 1 1 1 1 1 1 
Krt9 1 0.883 1 1 1 1 0.033 
Lcn2 1 1 1 1 1 1 1 
Lima1 1 1 1 1 1 1 1 
Limch1 1 1 1 1 1 1 1 
Lin28b 1 1 1 1 1 1 0 
Lipn 1 1 1 1 1 1 1 
ll24 1 1 1 1 1 1 1 
Lman1l 1 1 1 1 0.995 1 1 
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Loxl1 1 1 1 1 1 0.823 0.906 
Lpar6 1 1 1 1 1 1 1 
Lrch1 1 1 1 1 1 1 1 
Lrrc15 1 1 1 1 1 1 1 
Ltbp2 1 1 0.986 1 1 1 1 
Macrod2 0.986 0.941 0 0.965 0.163 1 1 
Mag 1 1 0.492 1 1 1 0.001 
Masp1 1 0.999 1 1 1 1 1 
Mdk 1 1 1 1 1 1 1 
Mdp1 1 0.681 1 1 1 1 1 
Mepce 1 1 1 1 1 1 0.92 
Mettl21c 1 0.894 1 1 1 1 0.077 
Mettl7b 1 1 0.93 0.308 0.563 0.129 0.002 
Mfsd10 1 0.998 1 1 1 1 1 
Mlx 1 1 1 1 1 1 1 
Mmp8 1 1 1 1 1 1 1 
Mos 1 1 1 1 1 1 1 
Moxd1 1 0.651 1 1 1 1 0.999 
Mpdz 1 1 1 1 1 1 1 
Mrgpre 1 1 1 1 1 1 1 
Mtmr3 1 1 1 1 1 1 1 
Myh1 1 1 0.233 0.001 0.001 0.999 0 
Mylip 1 0.589 0.007 1 1 0.044 1 
Myo3a 1 1 1 1 1 1 1 
Myo3b 1 1 0.999 0.017 0.997 0.003 1 
Myo7b 1 1 1 1 1 1 0.995 
Nat1 1 0.993 1 1 0.143 1 1 
Ncald 0.573 0.003 1 1 1 1 0.096 
Nefh 1 1 1 0.635 1 0.054 0.833 
Nek11 1 1 1 1 1 1 1 
Nek2 1 1 1 1 1 1 1 
Nes 1 1 1 0.463 1 0.04 0 
Neurl2 0.99 0.005 1 1 1 1 0.987 
Nfatc4 1 0.633 1 0.272 0.052 1 1 
Nmb 1 1 1 1 1 1 1 
Nmrk2 1 1 1 1 1 1 0.268 
Npm3 1 0.008 1 1 0.298 1 0.615 
Nrcam 1 0 0.999 0.658 0.011 1 1 
Nrn1l 1 0.998 1 1 0.375 1 0.96 
Nrsn1 1 1 1 1 1 1 1 
Nsun7 1 1 1 1 0.955 1 1 
Nt5c 1 0.997 1 1 1 1 1 
Nt5c1b 1 1 1 1 1 1 1 
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Oard1 1 1 1 1 1 1 1 
Ocstamp 1 1 1 1 1 1 0.698 
Ogn 1 1 1 1 1 1 0.987 
Osm 1 0.653 1 1 1 1 0.992 
Ovch2 1 1 1 1 1 1 1 
Pacsin2 1 1 1 1 1 1 1 
Paqr7 1 1 1 1 1 1 1 
Pard6a 1 1 1 0.916 0.911 1 1 
Parp16 1 0.146 0.985 1 1 0.732 1 
Parp8 0.382 1 0.636 1 0.995 1 0.993 
Pcdh12 1 1 1 1 1 1 1 
Pcsk4 1 1 1 1 1 1 1 
Pfdn6 1 1 0.983 1 1 1 1 
Pitx3 0 0 1 0 0 1 0.928 
Pkn3 1 1 1 1 1 1 1 
Pkp4 1 1 1 0.821 1 0.7 0 
Pla2g2d 1 1 1 1 1 1 1 
Plekha3 1 1 1 1 1 0.14 1 
Plk5 1 1 1 1 1 1 1 
Pnmt 1 1 1 1 0.905 0.999 0.99 
Postn 0.125 0.94 0 1 1 0.8 0.065 
Ppp1r26 1 1 1 1 1 1 1 
Ppp1r9b 0 0 0 0 0 0 0.824 
Prkab1 1 1 1 0.999 1 0.588 1 
Prokr1 1 1 1 1 1 1 0.665 
Prom2 1 0.257 1 1 1 0.62 1 
Prss40 0.999 1 1 1 1 1 1 
Prss56 1 1 1 1 1 1 1 
Ptpn20 1 1 1 1 1 1 1 
Ptpn5 0.18 1 0.326 1 1 0.999 1 
Ptpru 1 0.965 1 0.611 0 1 1 
Pycr1 1 1 0.998 1 1 1 0.949 
R3hcc1l 1 1 1 1 0.999 1 1 
Rab11fip5 1 1 1 1 1 1 1 
Rab20 1 1 1 1 1 1 1 
Rab24 0.704 0.093 1 1 1 1 1 
Rab27b 1 1 1 0.178 1 0.024 0.956 
Rab36 1 0.964 1 1 1 1 0 
Rab39 1 1 1 1 1 1 1 
Rab3c 1 1 1 1 1 1 1 
Rab3gap2 1 1 1 1 1 1 1 
Rab3ip 0.999 0.066 1 1 0.887 0.824 0.033 
Rab43 1 1 1 1 1 1 1 
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Rab5a 1 0.998 1 1 1 0.998 0.172 
Rabac1 1 1 1 1 1 1 1 
Rad21l 1 0.999 1 1 1 1 1 
Rap2b 1 1 1 0.967 1 0.969 1 
Rbm4b 1 1 1 1 1 1 1 
Resp18 1 1 0.978 1 1 1 1 
Rexo4 1 1 1 1 1 1 1 
Rhbdl2 1 1 1 1 1 1 0.999 
Rilpl2 1 1 1 1 1 1 1 
Rimklb 1 0.001 0.009 1 1 0 0.614 
Rin3 1 1 1 1 0.994 1 1 
Rnf10 1 1 1 0 0.874 0 1 
Rnf112 1 1 1 1 1 1 1 
Rnf13 1 1 1 1 1 1 0.052 
Rnf133 1 1 1 1 1 1 1 
Rnf25 1 0.158 1 0.234 1 0.056 1 
Rps6kl1 1 1 1 1 1 1 1 
Rrad 1 1 1 1 0.987 1 1 
Rxfp4 1 0.389 1 1 0.934 1 0.077 
Scg2 1 1 1 1 1 1 1 
Serpina1f 1 1 1 1 1 1 1 
Serpina7 1 1 1 1 1 1 1 
Serpinb5 1 0.007 1 1 0.242 0.176 0.955 
Setd6 1 0.991 1 1 0.984 1 1 
Sfxn4 1 1 1 1 1 1 1 
Sgta 1 0.999 1 1 1 1 1 
Sh3tc2 0.851 0.824 1 1 1 1 1 
Slc1a1 1 1 0.082 1 1 0.299 0.841 
Slc24a5 1 1 1 0.748 1 0.925 1 
Slc25a35 1 1 1 1 1 1 1 
Slc46a3 0.076 0 1 1 0.708 1 0.035 
Slc8a3 1 1 1 1 1 1 1 
Slc8b1 0.366 0 1 1 0.027 0.994 0.011 
Smoc2 1 0.07 1 1 0.989 1 1 
Snx15 1 0.197 1 1 1 1 0.835 
Sorbs2 1 1 1 1 0.97 1 1 
Sox18 1 1 1 1 0.194 1 0.821 
Sp5 1 1 1 1 1 0.993 1 
Spag4 1 1 1 1 1 1 1 
Spp1 1 1 1 1 1 1 1 
Sprr1b 1 1 1 1 1 0.986 1 
Sprr3 1 1 1 1 1 1 1 
Sptssb 1 1 1 1 1 1 1 
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Srcin1 1 1 1 1 1 1 1 
Stag3 1 1 1 1 1 0.375 1 
Stat5b 1 1 1 1 1 1 1 
Stk16 1 1 1 1 1 1 1 
Stx16 1 0.81 0.734 0.596 1 0.001 0.006 
Stx19 1 1 1 1 1 1 0.084 
Syce1 1 1 1 1 1 1 1 
Syce1l 1 1 1 1 1 1 1 
Sycp3 1 1 1 1 1 1 1 
Syn3 1 1 1 1 1 1 0.179 
Tas2r138 1 1 1 1 1 1 1 
Tbc1d4 1 1 1 1 1 1 1 
Tbx22 1 1 1 1 1 1 1 
Tdrkh 1 0.072 1 1 1 1 0.012 
Tex101 1 1 1 1 1 1 1 
Tex29 1 1 1 1 1 1 1 
Thsd1 1 0.989 1 1 1 1 0.307 
Timp3 1 1 1 1 1 0.996 1 
Tmem136 1 1 1 0.003 0.001 0.999 1 
Tmem151b 1 0.868 1 0.64 1 0.038 1 
Tmem181a 1 1 1 1 1 1 1 
Tmem79 0.112 0.003 1 0.851 0.053 1 1 
Tmod2 1 1 0.144 1 1 0.045 0.07 
Tnfsf18 0.468 0.992 1 0.856 0.991 0.952 0.667 
Tpcn1 1 1 1 1 1 1 1 
Tpgs2 0.046 1 0.247 0.394 1 0.997 0.99 
Tppp 1 1 1 0.581 1 0.691 0 
Tprn 0.939 1 0.85 1 1 1 1 
Trip13 1 1 1 1 1 1 1 
Try4 1 1 1 1 1 1 1 
Tspan18 1 1 1 0.926 1 0.977 1 
Tssk5 1 1 1 1 1 1 1 
Ttll10 1 1 1 1 1 1 1 
Ttll6 0.695 0.002 1 1 0.112 1 1 
Tubb4a 1 1 1 1 1 1 1 
Vcpkmt 1 0.999 1 1 1 1 1 
Vegfb 0.809 0.26 1 1 1 1 1 
Vsig4 0.032 1 0 1 1 0.074 0.957 
Vsig8 1 1 1 1 1 1 1 
Wee2 1 1 1 1 0.205 1 1 
Ydjc 0.453 0 1 1 1 1 1 
Ypel1 1 1 1 1 1 1 1 
Zbtb32 1 0.998 1 1 1 1 1 
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Zbtb4 1 0.073 1 0.999 0.016 1 1 
Zdhhc11 1 1 1 1 1 1 1 
Zfp14 1 1 1 1 0.798 1 1 
Zfp219 1 1 0.743 1 1 1 1 
Zfp689 1 1 1 1 1 1 0.01 
Zfp961 1 0 1 1 0.01 0.068 0.974 
Zfyve26 1 1 0.076 1 1 0.961 1 
Zzef1 1 1 0.792 0.998 1 0.009 0.384 
 
Supplementary Table A. 1.: p-values of individual genotypes for piezo variables from 
Dunnett’s Post Hoc analysis. 
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Supplementary Figure A. 1.: Visual representation of the differences in values for 
sleep variables in 55 KO strains that were found to be significant for one of more of 
these variables. The genotypes are arranged alphabetically for sleep percent (A. 24h, 
B. dark phase, C. light phase), and bout length (D. 24h, E. dark phase, F. light 
phase) measured in seconds as depicted on y axis. Each bar represents values 
between first and third quantile and the median (dot) for each KO cohort. Boxes 
marked in red represent the genes significant for a specific piezo variable. 
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A. 
 Daily sleep Percent Light Phase Percent Dark Phase Percent 
Genotype Male Female Male Female Male Female 
Cdc20 p<0.05 ↓ 1 p<0.05 ↓ 1 0.09 1 
Chn1 p<0.05 ↓ 1 0.11 1 1 1 
Mettl7b p<0.05 ↓ 1 1 0.82 p<0.05 ↓ 1 
Pitx3 p<0.05 ↓ p<0.05 ↓ p<0.05 ↓ p<0.05 ↓ 1 0.33 
Ppp1r9b p<0.05 ↓ p<0.05 ↓ p<0.05 ↓ p<0.05 ↓ p<0.05 ↓ p<0.05 ↓ 
Ptpn5 p<0.05 ↓ 1 1 1 p<0.05 ↓ 1 
Bzw2 0.25 0.41 p<0.05 ↓ 0.94 1 1 
Dnaja4 1 1 p<0.05 ↑ 0.96 1 1 
Epgn 1 1 p<0.05 ↑ 1 1 1 
Epha10 1 1 p<0.05 ↑ 1 1 0.98 
Hsd17b1 1 1 p<0.05 ↓ 1 0.36 1 
Htr1f 1 1 p<0.05 ↑ 0.81 1 1 
Parp16 1 1 p<0.05 ↓ 1 0.94 1 
Prom2 1 1 p<0.05 ↓ 1 1 1 
Slc8b1 1 0.11 p<0.05 ↑ p<0.05 ↑ 1 1 
Zfp961 1 1 p<0.05 ↑ 0.4 1 1 
Macrod2 1 1 1 1 p<0.05 ↑ p<0.05 ↑ 
Mylip 1 1 0.9 1 p<0.05 ↓ 0.51 
Parp8 0.1 1 1 1 p<0.05 ↑ 1 
Postn 1 0.93 0.7 1 p<0.05 ↑ p<0.05 ↑ 
Tmod2 0.33 1 1 1 p<0.05 ↓ 1 
Ap4e1 0.99 p<0.05 ↓ 1 0.67 1 0.31 
Nfatc4 1 1 1 1 1 1 
Rimklb 1 1 0.2 0.21 0.31 0.08 
Rnf10 1 1 1 1 1 1 
Nat1 1 1 0.29 1 1 1 
Stx16 1 1 1 1 0.61 1 
Tmem151b 1 1 1 1 1 1 
Zzef1 0.91 1 1 1 0.66 1 
Adck2 1 1 0.77 1 1 1 
Myh1 1 0.33 0.42 1 1 p<0.05 ↑ 
Nes 1 1 0.98 1 1 1 
Cbln3 1 p<0.05 ↑ 1 0.06 0.44 p<0.05 ↑ 
Ccl26 1 p<0.05 ↑ 1 p<0.05 ↑ 1 0.32 
Col18a1 1 p<0.05 ↓ 1 p<0.05 ↓ 1 1 
Rab24 1 p<0.05 ↑ 1 0.51 1 0.98 
Tmem79 1 p<0.05 ↓ 0.92 0.06 1 1 
Ydjc 1 p<0.05 ↑ 1 p<0.05 ↑ 1 1 
Cpb1 1 0.69 1 p<0.05 ↑ 0.29 1 
Kcnh3 1 0.39 1 p<0.05 ↓ 0.89 1 
Npm3 1 1 1 p<0.05 ↑ 1 1 
Nrcam 1 1 0.83 p<0.05 ↓ 1 0.97 
Serpinb5 1 0.91 1 p<0.05 ↑ 1 1 
Slc46a3 1 0.11 0.13 p<0.05 ↑ 1 1 
Zbtb4 1 0.35 1 p<0.05 ↑ 1 1 
Arrb2 0.27 0.8 1 1 0.39 p<0.05 ↓ 
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Vsig4 1 0.06 1 1 0.94 p<0.05 ↓ 
Zfyve26 1 0.94 1 1 0.87 p<0.05 ↓ 
Ghrhr 1 1 1 1 1 0.91 
Prss56 1 1 1 1 1 0.88 
Tmem136 1 1 1 1 1 1 
Ipp 1 1 1 0.09 1 1 
Nrn1l 1 1 1 1 1 1 
Ptpru 1 1 1 1 1 1 
 
 
B 
 Sleep Bout Length Light Phase Bout Length Dark Phase Bout Length 
Genotype Male Female Male Female Male Female 
Cdc20 1 1 1 1 0.18 1 
Chn1 1 1 1 1 1 1 
Mettl7b p<0.05 ↓ 1 p<0.05 ↓ 1 0.12 1 
Pitx3 p<0.05 ↓ p<0.05 ↓ p<0.05 ↓ p<0.05 ↓ 0.89 p<0.05 ↓ 
Ppp1r9b p<0.05 ↓ 0.67 0.1 0.14 p<0.05 ↓ 0.14 
Ptpn5 1 1 1 1 0.13 1 
Bzw2 1 1 0.45 1 1 1 
Dnaja4 1 1 1 1 0.94 1 
Epgn 1 1 1 1 0.66 1 
Epha10 1 1 1 0.98 1 0.98 
Hsd17b1 p<0.05 ↓ p<0.05 ↓ p<0.05 ↓ p<0.05 ↓ 1 p<0.05 ↓ 
Htr1f 1 1 1 1 1 1 
Parp16 1 1 1 1 0.57 1 
Prom2 1 1 1 1 0.58 1 
Slc8b1 1 1 0.94 p<0.05 ↑ 1 p<0.05 ↑ 
Zfp961 1 1 p<0.05 ↑ 1 p<0.05 ↓ 1 
Macrod2 1 0.78 1 0.09 1 0.09 
Mylip 1 1 1 1 0.15 1 
Parp8 1 1 0.8 1 1 1 
Postn 1 1 1 1 1 1 
Tmod2 1 1 1 1 p<0.05 ↓ 1 
Ap4e1 p<0.05 ↓ 0.68 0.39 0.5 p<0.05 ↓ 0.5 
Nfatc4 p<0.05 ↑ 1 p<0.05 ↑ 1 1 1 
Rimklb p<0.05 ↓ 1 1 0.92 p<0.05 ↓ 0.92 
Rnf10 p<0.05 ↓ 0.99 0.53 1 p<0.05 ↓ 1 
Nat1 0.99 1 p<0.05 ↑ 1 1 1 
Stx16 0.18 1 1 1 p<0.05 ↓ 1 
Tmem151b 0.07 1 1 1 p<0.05 ↓ 1 
Zzef1 0.96 1 1 1 p<0.05 ↓ 1 
Adck2 1 1 1 p<0.05 ↑ 0.95 p<0.05 ↑ 
Myh1 0.1 p<0.05 ↓ 0.08 0.2 1 0.2 
Nes 1 p<0.05 ↓ 1 0.95 0.23 0.95 
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Cbln3 1 0.99 1 1 1 1 
Ccl26 1 1 1 0.96 1 0.96 
Col18a1 1 1 1 1 1 1 
Rab24 1 0.93 1 1 1 1 
Tmem79 0.91 1 0.17 1 1 1 
Ydjc 1 1 1 0.93 1 0.93 
Cpb1 1 1 1 0.78 0.71 0.78 
Kcnh3 1 0.64 0.99 1 1 1 
Npm3 1 1 1 0.76 1 0.76 
Nrcam 1 0.98 0.94 0.4 1 0.4 
Serpinb5 1 1 1 0.17 0.94 0.17 
Slc46a3 1 1 1 0.51 1 0.51 
Zbtb4 1 0.19 1 p<0.05 ↑ 1 p<0.05 ↑ 
Arrb2 1 0.9 1 0.16 1 0.16 
Vsig4 1 1 1 1 0.99 1 
Zfyve26 1 1 1 1 1 1 
Ghrhr 1 p<0.05 ↑ 1 1 1 1 
Prss56 1 p<0.05 ↑ 1 0.91 1 0.91 
Tmem136 0.76 p<0.05 ↑ 0.16 0.05 1 0.05 
Ipp 1 1 1 p<0.05 ↑ 1 p<0.05 ↑ 
Nrn1l 1 0.12 1 p<0.05 ↑ 1 p<0.05 ↑ 
Ptpru 1 0.6 0.43 p<0.05 ↓ 1 p<0.05 ↓ 
 
 
Supplementary Table A. 2.: Sex differences in significant genotypes for (A) sleep 
percent and (B) bout lengths with direction of change. ↑ represents values higher than 
Control animals, and ↓ represent values lower than Controls. P-values were 
calculating through Dunnett’s Post Hoc analysis. 
 
Genotype Per1 Per2 Clock Bmal1/Arntl Homer1 Sik3 Nalcn 
Ap4e1 1 0 0 0 0 0 0 
BC030499 0 0 0 0 0 1 0 
Bex4 1 0 0 0 0 0 0 
Cacna2d3 1 0 1 1 0 0 1 
Chn1 0 0 0 0 1 0 0 
Dcaf10 0 0 1 0 0 0 0 
Dnaja4 0 0 1 0 0 0 0 
Eogt 1 0 0 0 0 0 0 
Epgn 0 0 0 1 0 0 0 
Ermp1 0 1 0 0 0 0 0 
Foxo3 0 1 0 0 0 0 0 
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H1fx 1 0 0 0 0 0 0 
Htr1f 0 0 0 1 0 0 0 
Igsf11 1 0 0 0 0 0 0 
Ipp 0 0 0 1 0 0 0 
Kcnh3 1 1 1 1 0 0 0 
Loxl1 1 0 0 0 0 0 0 
Mos 0 0 0 0 0 1 0 
Myo3a 0 0 0 1 0 0 1 
Myo3b 0 0 0 0 1 0 0 
Nat1 0 0 0 0 1 0 0 
Ncald 0 0 0 0 0 0 1 
Nek2 0 0 0 0 0 1 0 
Nes 1 0 0 0 0 0 0 
Nrcam 0 0 1 0 0 0 0 
Parp16 0 0 0 0 1 0 0 
Parp8 0 0 0 1 0 0 0 
Pkp4 0 1 0 0 0 0 0 
Ppp1r9b 1 0 0 0 0 0 0 
Prom1 0 1 1 0 0 0 0 
Ptpn5 0 0 0 0 0 0 1 
Ptpru 1 0 0 0 0 0 0 
Rab27b 0 0 1 0 0 0 0 
Rab36 0 0 0 0 0 0 1 
Rnf25 1 0 0 0 0 0 0 
Slc46a3 0 1 0 0 0 0 0 
Srcin1 0 0 0 0 0 0 1 
Stx16 0 0 0 0 0 1 0 
Tpgs2 0 0 1 1 0 0 0 
Tppp 0 0 0 0 1 0 1 
 
Supplementary Table A. 3.: Binary table representing connections in gene network 
analysis. 1 indicates that gene is part of the network.  
 
Genotype Count 
Ap4e1 20 
Pitx3 20 
Rnf10 20 
Myh1 20 
Ghrhr 20 
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Chn1 20 
Ncald 18 
Tppp 15 
Foxo3 14 
Macrod2 14 
Vsig4 12 
Hsd17b1 12 
Postn 12 
Mag 12 
Ydjc 11 
Bzw2 10 
Rimklb 9 
Stx16 9 
Pkp4 9 
Ppp1r9b 8 
Tmem79 8 
Zzef1 8 
Cdc20 7 
Tpgs2 7 
Arrb2 7 
Prom2 7 
Kcnh3 6 
Ajap1 6 
H1fx 6 
Ptpn5 6 
Loxl1 6 
Rab24 6 
Prss56 6 
Tmem151b 5 
Dcaf10 5 
Parp8 5 
Cldn13 5 
Rab3ip 5 
Prokr1 5 
Rab36 5 
Cbln3 4 
Htr3b 4 
Htr1f 4 
Serpinb5 4 
Epgn 4 
Mylip 4 
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Adck2 4 
Tmod2 4 
Rnf25 4 
Mettl7b 4 
Cers5 4 
Thsd1 4 
Ccl26 3 
Neurl2 3 
Eogt 3 
Slc8b1 3 
Zbtb4 3 
Ptpru 3 
Gipc3 3 
Slc1a1 3 
Acsf2 3 
Cfb 3 
Dnaja4 2 
Slc46a3 2 
Npm3 2 
Tmem136 2 
Myo3b 2 
Arf2 2 
Zfp219 2 
Sox18 2 
Carf 2 
Lin28b 2 
Rxfp4 2 
Zfp689 2 
Col18a1 2 
Crym 2 
Nrcam 1 
Cpb1 1 
Gjd4 1 
Ifnl3 1 
Ttll6 1 
Zfp961 1 
Bex4 1 
Ermp1 1 
Htr1d 1 
Ipp 1 
Rab27b 1 
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Nes 1 
Dnajc14 1 
Epha10 1 
Nfatc4 1 
Parp16 1 
Tdrkh 1 
Nat1 1 
BC030499 1 
C1qa 1 
Ces4a 1 
Il12rb2 1 
Zfyve26 1 
Nrn1l 1 
Igsf11 NA 
Akr1d1 NA 
Cacna2d3 NA 
Enox1 NA 
Fndc4 NA 
Galnt12 NA 
Gpr156 NA 
Masp1 NA 
Mos NA 
Myo3a NA 
Nek2 NA 
Ovch2 NA 
Pfdn6 NA 
Rab3c NA 
Rab3gap2 NA 
Rbm4b NA 
Srcin1 NA 
Tas2r138 NA 
Tnfsf18 NA 
Tubb4a NA 
Cd84 NA 
Krt9 NA 
 
Supplementary Table A. 4.: Count of gene-MP Term associations. Column “Count” 
represents the number of mammalian phenotype (MP) terms a single gene was 
associated with. 
 
90 
 
MP Term Count 
abnormal sleep behavior 37 
abnormal behavioral response to light 23 
decreased circulating glucose level 22 
Info not available 22 
decreased total body fat amount 20 
abnormal behavior 16 
hyperactivity 14 
abnormal bone structure 14 
decreased bone mineral content 14 
decreased lean body mass 12 
increased circulating sodium level 11 
decreased bone mineral density 11 
increased circulating alkaline phosphatase level 10 
decreased circulating insulin level 10 
decreased grip strength 10 
increased lean body mass 9 
decreased body length 8 
increased hematocrit 8 
increased circulating potassium level 8 
impaired righting response 8 
increased fasted circulating glucose level 7 
hypoactivity 7 
convulsive seizures 7 
abnormal retinal pigmentation 7 
increased bone mineral content 6 
decreased leukocyte cell number 6 
increased mean corpuscular volume 6 
increased mean corpuscular hemoglobin 6 
increased hemoglobin content 6 
decreased circulating triglyceride level 6 
abnormal retina morphology 6 
abnormal QRS complex 5 
increased erythrocyte cell number 5 
improved glucose tolerance 5 
decreased circulating free fatty acid level 5 
abnormal coat appearance 5 
shortened RR interval 4 
increased body length 4 
increased bone mineral density 4 
increased or absent threshold for auditory brainstem response 4 
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preweaning lethality, incomplete penetrance 4 
increased exploration in new environment 4 
decreased vertical activity 4 
increased grip strength 4 
decreased exploration in new environment 4 
increased vertical activity 4 
decreased startle reflex 4 
decreased anxiety-related response 4 
persistence of hyaloid vascular system 4 
decreased heart weight 3 
cardiovascular system phenotype 3 
decreased mean corpuscular hemoglobin concentration 3 
thrombocytopenia 3 
decreased threshold for auditory brainstem response 3 
increased circulating HDL cholesterol level 3 
decreased circulating HDL cholesterol level 3 
decreased circulating cholesterol level 3 
decreased circulating chloride level 3 
decreased prepulse inhibition 3 
increased total body fat amount 2 
increased heart rate 2 
shortened PQ interval 2 
increased heart weight 2 
increased mean corpuscular hemoglobin concentration 2 
decreased mean corpuscular hemoglobin 2 
increased blood urea nitrogen level 2 
increased circulating glucose level 2 
decreased fasted circulating glucose level 2 
increased circulating chloride level 2 
decreased blood urea nitrogen level 2 
enlarged lymph nodes 2 
abnormal coat/hair pigmentation 2 
increased prepulse inhibition 2 
increased coping response 2 
straub tail 2 
limb grasping 2 
abnormal motor coordination/ balance 2 
abnormal kidney morphology 2 
male infertility 2 
decreased heart rate variability 1 
abnormal heart morphology 1 
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shortened ST segment 1 
abnormal retinal blood vessel morphology 1 
prolonged QRS complex duration 1 
thin ventricular wall 1 
shortened PR interval 1 
prolonged PQ interval 1 
prolonged ST segment 1 
absent teeth 1 
increased body weight 1 
abnormal head morphology 1 
enlarged spleen 1 
increased gamma-delta T cell number 1 
decreased alpha-beta T cell number 1 
increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number 1 
decreased erythrocyte cell number 1 
increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number 1 
decreased Ly6C-positive NK T cell number 1 
increased marginal zone B cell number 1 
decreased hemoglobin content 1 
increased leukocyte cell number 1 
decreased mean corpuscular volume 1 
decreased memory-marker CD4-negative NK T cell number 1 
decreased effector memory T-helper cell number 1 
increased CD8-positive, naive alpha-beta T cell number 1 
decreased macrophage cell number 1 
increased CD8-positive, alpha-beta T cell number 1 
decreased basophil cell number 1 
decreased eosinophil cell number 1 
decreased circulating amylase level 1 
increased circulating alanine transaminase level 1 
increased circulating bilirubin level 1 
decreased circulating serum albumin level 1 
decreased circulating alkaline phosphatase level 1 
decreased urine creatinine level 1 
increased circulating phosphate level 1 
increased circulating iron level 1 
decreased circulating iron level 1 
decreased circulating phosphate level 1 
decreased circulating alanine transaminase level 1 
immune system phenotype 1 
abnormal nail morphology 1 
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short tail 1 
abnormal digit morphology 1 
preweaning lethality, complete penetrance 1 
embryonic lethality prior to tooth bud stage 1 
embryonic lethality prior to organogenesis 1 
prenatal lethality prior to heart atrial septation 1 
abnormal social/conspecific interaction 1 
impaired pupillary reflex 1 
jumpy 1 
absent startle reflex 1 
abnormal vocalization 1 
abnormal motor learning 1 
decreased coping response 1 
increased startle reflex 1 
tremors 1 
abnormal whole-body plethysmography 1 
increased tidal volume 1 
decreased pulmonary respiratory rate 1 
increased sacral vertebrae number 1 
anophthalmia 1 
abnormal eyelid aperture 1 
mydriasis 1 
abnormal lens morphology 1 
decreased cornea thickness 1 
fused cornea and lens 1 
 
Supplementary Table A. 5.: Frequency of MP Terms. Column “Count” represents 
the number of times a mammalian phenotype (MP) term was associated with a gene. 
 
 
marker_symbol mp_term 
Ppp1r9b 
hyperactivity|increased exploration in new environment|abnormal 
behavior|abnormal sleep behavior|abnormal bone structure|decreased 
lean body mass|decreased body length|increased coping response 
Cbln3 
abnormal retina morphology|increased blood urea nitrogen 
level|shortened RR interval|straub tail 
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Ap4e1 
limb grasping|enlarged spleen|increased circulating alkaline phosphatase 
level|increased mean corpuscular hemoglobin concentration|decreased 
mean corpuscular hemoglobin|hyperactivity|decreased vertical 
activity|decreased heart weight|decreased grip strength|enlarged lymph 
nodes|increased gamma-delta T cell number|decreased heart rate 
variability|increased sacral vertebrae number|decreased alpha-beta T 
cell number|abnormal heart morphology|cardiovascular system 
phenotype|abnormal kidney morphology|decreased circulating glucose 
level|increased lean body mass|abnormal bone structure 
Cdc20 
preweaning lethality, complete penetrance|embryonic lethality prior to 
tooth bud stage|increased grip strength|improved glucose 
tolerance|decreased circulating glucose level|increased circulating 
glucose level|embryonic lethality prior to organogenesis 
Bzw2 
increased body length|increased bone mineral content|decreased 
circulating glucose level|decreased total body fat amount|increased lean 
body mass|abnormal sleep behavior|abnormal bone 
structure|shortened RR interval|increased bone mineral 
density|increased circulating glucose level 
Tpgs2 
decreased bone mineral content|decreased exploration in new 
environment|abnormal sleep behavior|abnormal bone structure|male 
infertility|decreased body length|decreased circulating free fatty acid 
level 
Pitx3 
hypoactivity|increased circulating alkaline phosphatase level|increased 
heart rate|decreased vertical activity|decreased bone mineral 
content|anophthalmia|decreased exploration in new 
environment|decreased lean body mass|abnormal bone 
structure|abnormal social/conspecific interaction|shortened ST 
segment|abnormal behavioral response to light|increased grip 
strength|increased exploration in new environment|decreased 
circulating triglyceride level|decreased circulating amylase 
level|decreased total body fat amount|abnormal eyelid 
aperture|abnormal sleep behavior|increased body weight 
Ccl26 
decreased circulating insulin level|abnormal behavioral response to 
light|improved glucose tolerance 
Vsig4 
decreased leukocyte cell number|hyperactivity|increased circulating 
alanine transaminase level|improved glucose tolerance|decreased 
circulating glucose level|increased vertical activity|abnormal 
behavior|decreased grip strength|increased circulating potassium 
level|abnormal behavioral response to light|shortened PQ 
interval|abnormal sleep behavior 
Nrcam increased fasted circulating glucose level 
Htr3b 
increased body length|decreased bone mineral density|increased bone 
mineral density|decreased grip strength 
Kcnh3 
cardiovascular system phenotype|increased circulating HDL cholesterol 
level|abnormal retinal pigmentation|increased fasted circulating glucose 
level|abnormal sleep behavior|increased CD4-positive, CD25-positive, 
alpha-beta regulatory T cell number 
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Ncald 
increased circulating alkaline phosphatase level|decreased circulating 
HDL cholesterol level|hyperactivity|decreased bone mineral 
content|decreased circulating glucose level|increased circulating sodium 
level|abnormal behavior|impaired pupillary reflex|decreased bone 
mineral density|decreased lean body mass|abnormal bone 
structure|mydriasis|decreased mean corpuscular hemoglobin 
concentration|decreased total body fat amount|abnormal sleep 
behavior|increased total body fat amount|decreased body 
length|abnormal retinal blood vessel morphology 
Foxo3 
hypoactivity|increased mean corpuscular 
volume|thrombocytopenia|increased mean corpuscular 
hemoglobin|decreased prepulse inhibition|abnormal retina 
morphology|decreased bone mineral density|prolonged QRS complex 
duration|abnormal behavioral response to light|abnormal retinal 
pigmentation|decreased startle reflex|decreased total body fat 
amount|decreased erythrocyte cell number|abnormal sleep behavior 
Rimklb 
abnormal behavioral response to light|decreased leukocyte cell 
number|hyperactivity|increased bone mineral content|abnormal 
behavior|decreased circulating triglyceride level|decreased total body fat 
amount|increased lean body mass|abnormal sleep behavior 
Htr1f 
increased mean corpuscular volume|cardiovascular system 
phenotype|increased circulating sodium level|short tail 
Dnaja4 decreased circulating glucose level|increased circulating bilirubin level 
Ydjc 
increased memory CD4-positive, CD25-positive, alpha-beta regulatory T 
cell number|increased circulating alkaline phosphatase level|abnormal 
behavioral response to light|increased hemoglobin content|decreased 
circulating glucose level|increased circulating sodium level|increased 
hematocrit|abnormal retinal pigmentation|abnormal retina 
morphology|increased lean body mass|increased erythrocyte cell 
number 
Cpb1 Info not available 
Gjd4 Info not available 
Ifnl3 Info not available 
Serpinb5 
increased mean corpuscular volume|decreased total body fat 
amount|decreased grip strength|decreased body length 
Slc46a3 abnormal coat appearance|abnormal behavioral response to light 
Neurl2 
abnormal coat appearance|decreased circulating glucose level|abnormal 
QRS complex 
Eogt hypoactivity|decreased circulating insulin level|abnormal behavior 
Epgn 
decreased circulating insulin level|increased hematocrit|decreased 
circulating glucose level|impaired righting response 
Npm3 abnormal behavioral response to light|decreased circulating glucose level 
Slc8b1 
abnormal coat appearance|decreased circulating glucose level|impaired 
righting response 
Ttll6 decreased circulating glucose level 
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Hsd17b1 
increased circulating alkaline phosphatase level|decreased circulating 
glucose level|abnormal behavior|abnormal retina 
morphology|decreased exploration in new environment|impaired 
righting response|increased circulating potassium level|abnormal 
behavioral response to light|abnormal retinal pigmentation|abnormal 
lens morphology|abnormal sleep behavior|abnormal motor 
coordination/ balance 
Zfp961 decreased threshold for auditory brainstem response 
Bex4 Info not available 
Tmem79 
abnormal coat appearance|abnormal behavioral response to 
light|abnormal retinal pigmentation|decreased fasted circulating glucose 
level|decreased startle reflex|decreased total body fat 
amount|increased lean body mass|abnormal sleep behavior 
Macrod2 
hyperactivity|improved glucose tolerance|convulsive seizures|increased 
vertical activity|abnormal behavior|abnormal retina 
morphology|decreased lean body mass|decreased circulating insulin 
level|abnormal behavioral response to light|increased bone mineral 
content|increased fasted circulating glucose level|increased blood urea 
nitrogen level|abnormal sleep behavior|decreased body length 
Mylip 
hyperactivity|increased exploration in new environment|abnormal 
behavior|abnormal sleep behavior 
Postn 
increased circulating alkaline phosphatase level|decreased bone mineral 
content|decreased heart weight|decreased bone mineral 
density|abnormal bone structure|decreased lean body mass|impaired 
righting response|increased circulating potassium level|abnormal 
behavioral response to light|decreased total body fat amount|abnormal 
sleep behavior|decreased body length 
Tmem136 decreased bone mineral content|abnormal sleep behavior 
Rnf10 
limb grasping|hypoactivity|hyperactivity|improved glucose 
tolerance|jumpy|abnormal digit morphology|decreased cornea 
thickness|decreased grip strength|preweaning lethality, incomplete 
penetrance|straub tail|decreased circulating serum albumin 
level|prenatal lethality prior to heart atrial septation|decreased Ly6C-
positive NK T cell number|thin ventricular wall|increased marginal zone B 
cell number|decreased circulating alkaline phosphatase level|decreased 
body length|decreased circulating cholesterol level|increased circulating 
HDL cholesterol level|increased circulating chloride level 
Myo3b convulsive seizures|abnormal sleep behavior 
Myh1 
absent startle reflex|decreased leukocyte cell number|increased 
hemoglobin content|decreased vertical activity|decreased bone mineral 
content|convulsive seizures|decreased exploration in new 
environment|decreased bone mineral density|decreased lean body 
mass|abnormal bone structure|decreased grip strength|abnormal 
behavioral response to light|increased hematocrit|abnormal 
vocalization|decreased startle reflex|decreased total body fat 
amount|decreased anxiety-related response|increased erythrocyte cell 
number|decreased urine creatinine level|abnormal sleep behavior 
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Arrb2 
increased circulating phosphate level|increased circulating alkaline 
phosphatase level|increased circulating HDL cholesterol 
level|thrombocytopenia|increased grip strength|decreased total body 
fat amount|increased circulating potassium level 
Ermp1 decreased prepulse inhibition 
Zbtb4 
hyperactivity|fused cornea and lens|persistence of hyaloid vascular 
system 
Htr1d Info not available 
Adck2 
abnormal motor learning|increased circulating sodium level|abnormal 
behavior|increased circulating potassium level 
Ipp decreased leukocyte cell number 
Ptpru 
increased vertical activity|abnormal sleep behavior|persistence of 
hyaloid vascular system 
Ghrhr 
decreased circulating cholesterol level|decreased circulating HDL 
cholesterol level|decreased mean corpuscular hemoglobin|decreased 
vertical activity|thrombocytopenia|decreased bone mineral 
content|decreased hemoglobin content|decreased circulating glucose 
level|decreased heart weight|decreased bone mineral density|decreased 
lean body mass|abnormal bone structure|decreased grip 
strength|shortened PR interval|abnormal behavioral response to 
light|increased grip strength|decreased mean corpuscular hemoglobin 
concentration|shortened PQ interval|abnormal sleep behavior|increased 
leukocyte cell number 
Rab27b Info not available 
Zzef1 
increased mean corpuscular hemoglobin|decreased total body fat 
amount|absent teeth|abnormal sleep behavior|decreased grip 
strength|decreased circulating free fatty acid level|increased coping 
response|increased circulating potassium level 
Tmem151b 
abnormal behavioral response to light|hyperactivity|increased circulating 
sodium level|abnormal behavior|abnormal sleep behavior 
Stx16 
decreased circulating insulin level|increased exploration in new 
environment|increased bone mineral content|abnormal 
behavior|decreased circulating triglyceride level|decreased total body fat 
amount|increased lean body mass|abnormal sleep behavior|abnormal 
QRS complex 
Nes abnormal sleep behavior 
Tmod2 
abnormal behavioral response to light|hyperactivity|abnormal 
behavior|abnormal sleep behavior 
Dcaf10 
increased mean corpuscular volume|abnormal behavioral response to 
light|abnormal behavior|increased mean corpuscular 
hemoglobin|decreased anxiety-related response 
Parp8 
hypoactivity|decreased coping response|abnormal behavioral response 
to light|abnormal retina morphology|abnormal sleep behavior 
Rnf25 
decreased circulating chloride level|hypoactivity|abnormal behavioral 
response to light|abnormal behavior 
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Ajap1 
decreased bone mineral content|increased startle reflex|increased 
circulating sodium level|abnormal sleep behavior|abnormal bone 
structure|increased circulating potassium level 
Arf2 abnormal coat/hair pigmentation|increased hematocrit 
Cldn13 
decreased mean corpuscular volume|decreased fasted circulating glucose 
level|increased erythrocyte cell number|decreased blood urea nitrogen 
level|increased circulating potassium level 
Dnajc14 increased or absent threshold for auditory brainstem response 
Epha10 impaired righting response 
Gipc3 
decreased startle reflex|decreased prepulse inhibition|increased or 
absent threshold for auditory brainstem response 
H1fx 
increased circulating sodium level|increased fasted circulating glucose 
level|decreased total body fat amount|increased lean body 
mass|abnormal sleep behavior|shortened RR interval 
Nfatc4 Info not available 
Parp16 Info not available 
Rab3ip 
decreased circulating insulin level|increased circulating alkaline 
phosphatase level|decreased bone mineral content|decreased bone 
mineral density|increased prepulse inhibition 
Slc1a1 
increased circulating iron level|decreased total body fat 
amount|persistence of hyaloid vascular system 
Tdrkh Info not available 
Zfp219 convulsive seizures|decreased circulating glucose level 
Chn1 
hypoactivity|increased circulating alkaline phosphatase level|decreased 
circulating HDL cholesterol level|increased mean corpuscular 
volume|hyperactivity|decreased circulating iron level|increased 
hemoglobin content|decreased bone mineral content|decreased 
circulating glucose level|increased circulating sodium level|abnormal 
behavior|increased mean corpuscular hemoglobin|increased lean body 
mass|decreased bone mineral density|impaired righting 
response|preweaning lethality, incomplete penetrance|decreased 
circulating insulin level|abnormal behavioral response to light|decreased 
mean corpuscular hemoglobin concentration|increased hematocrit 
Mettl7b 
decreased circulating chloride level|abnormal coat/hair 
pigmentation|decreased circulating glucose level|abnormal sleep 
behavior 
Ptpn5 
increased heart weight|decreased leukocyte cell number|increased bone 
mineral content|abnormal sleep behavior|abnormal bone 
structure|increased prepulse inhibition 
Prom2 
decreased circulating insulin level|hyperactivity|abnormal retinal 
pigmentation|abnormal nail morphology|decreased memory-marker 
CD4-negative NK T cell number|decreased grip strength|abnormal QRS 
complex 
Nat1 abnormal sleep behavior 
Sox18 abnormal behavior|decreased blood urea nitrogen level 
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Acsf2 
abnormal behavioral response to light|increased mean corpuscular 
hemoglobin|decreased total body fat amount 
BC030499 Info not available 
C1qa decreased circulating glucose level 
Carf prolonged PQ interval|prolonged ST segment 
Cers5 
decreased bone mineral content|increased circulating sodium 
level|decreased lean body mass|abnormal motor coordination/ balance 
Ces4a Info not available 
Cfb 
increased hemoglobin content|increased hematocrit|increased 
erythrocyte cell number 
Il12rb2 decreased circulating free fatty acid level 
Lin28b increased heart rate|shortened RR interval 
Loxl1 
increased body length|convulsive seizures|increased fasted circulating 
glucose level|decreased threshold for auditory brainstem 
response|abnormal sleep behavior|abnormal QRS complex 
Mag 
abnormal whole-body plethysmography|convulsive seizures|decreased 
circulating glucose level|decreased circulating phosphate level|decreased 
circulating insulin level|increased tidal volume|tremors|decreased 
circulating triglyceride level|decreased total body fat amount|abnormal 
sleep behavior|increased or absent threshold for auditory brainstem 
response|decreased pulmonary respiratory rate 
Pkp4 
decreased bone mineral content|increased bone mineral 
content|increased hematocrit|decreased total body fat 
amount|increased lean body mass|decreased bone mineral 
density|abnormal sleep behavior|abnormal bone structure|impaired 
righting response 
Prokr1 
increased body length|abnormal retinal pigmentation|decreased 
circulating glucose level|abnormal sleep behavior|increased bone 
mineral density 
Rab36 
decreased circulating cholesterol level|increased mean corpuscular 
hemoglobin concentration|increased hemoglobin content|abnormal 
head morphology|decreased circulating triglyceride level 
Rxfp4 
decreased circulating chloride level|increased fasted circulating glucose 
level 
Thsd1 
increased mean corpuscular volume|increased mean corpuscular 
hemoglobin|decreased total body fat amount|decreased circulating free 
fatty acid level 
Tppp 
increased circulating alkaline phosphatase level|hyperactivity|increased 
hemoglobin content|decreased bone mineral content|increased 
circulating chloride level|convulsive seizures|decreased bone mineral 
density|decreased lean body mass|abnormal bone structure|abnormal 
behavioral response to light|increased hematocrit|decreased anxiety-
related response|increased erythrocyte cell number|abnormal sleep 
behavior|decreased body length 
Zfp689 abnormal sleep behavior|preweaning lethality, incomplete penetrance 
Col18a1 increased fasted circulating glucose level|increased vertical activity 
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Rab24 
abnormal coat appearance|decreased bone mineral content|decreased 
anxiety-related response|decreased bone mineral density|abnormal 
bone structure|decreased lean body mass 
Zfyve26 increased or absent threshold for auditory brainstem response 
Prss56 
decreased effector memory T-helper cell number|increased CD8-positive, 
naive alpha-beta T cell number|decreased leukocyte cell 
number|decreased macrophage cell number|immune system 
phenotype|increased CD8-positive, alpha-beta T cell number 
Nrn1l decreased circulating glucose level 
Crym abnormal sleep behavior|decreased grip strength 
Igsf11 male infertility 
Akr1d1 persistence of hyaloid vascular system 
Cacna2d3 
decreased circulating glucose level|increased circulating sodium 
level|decreased circulating free fatty acid level 
Enox1 
decreased threshold for auditory brainstem response|decreased lean 
body mass|increased bone mineral density|increased total body fat 
amount 
Fndc4 Info not available 
Galnt12 Info not available 
Gpr156 Info not available 
Masp1 Info not available 
Mos Info not available 
Myo3a abnormal behavioral response to light 
Nek2 
decreased basophil cell number|abnormal kidney morphology|decreased 
eosinophil cell number|enlarged lymph nodes 
Ovch2 Info not available 
Pfdn6 impaired righting response|preweaning lethality, incomplete penetrance 
Rab3c Info not available 
Rab3gap2 Info not available 
Rbm4b Info not available 
Srcin1 
increased heart weight|decreased total body fat amount|abnormal QRS 
complex 
Tas2r138 Info not available 
Tnfsf18 decreased lean body mass 
Tubb4a Info not available 
Cd84 
increased circulating sodium level|decreased circulating triglyceride 
level|decreased total body fat amount|decreased circulating alanine 
transaminase level 
Krt9 decreased circulating insulin level 
 
Supplementary Table A. 6.: Mammalian Phenotype (MP) terms associated with 
sleep related candidate genes from KOMP2 
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Supplementary Figure A. 2.: Jaccard Analysis for geneset similarities from 12 
shortlisted genelists from Geneweaver 
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